| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neurexin family protein binding | 4.76e-07 | 16 | 209 | 5 | GO:0042043 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 9.75e-07 | 51 | 209 | 7 | GO:0043394 | |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 1.11e-05 | 5 | 209 | 3 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 1.11e-05 | 5 | 209 | 3 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 1.11e-05 | 5 | 209 | 3 | GO:0000827 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 1.11e-05 | 5 | 209 | 3 | GO:0000832 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | ADAMTS15 MME UQCRC2 CNDP1 DPP3 XPNPEP2 PRPF8 ADAMTS12 RNPEP LTA4H | 5.09e-05 | 200 | 209 | 10 | GO:0008237 |
| GeneOntologyMolecularFunction | syndecan binding | 9.06e-05 | 9 | 209 | 3 | GO:0045545 | |
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 1.09e-04 | 2 | 209 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | IMP dehydrogenase activity | 1.09e-04 | 2 | 209 | 2 | GO:0003938 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 1.59e-04 | 110 | 209 | 7 | GO:0008238 | |
| GeneOntologyMolecularFunction | inositol phosphate kinase activity | 1.75e-04 | 11 | 209 | 3 | GO:0180030 | |
| GeneOntologyMolecularFunction | glycerol kinase activity | 3.25e-04 | 3 | 209 | 2 | GO:0004370 | |
| GeneOntologyMolecularFunction | denatured protein binding | 3.25e-04 | 3 | 209 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 4.38e-04 | 93 | 209 | 6 | GO:0097110 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 4.69e-04 | 15 | 209 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PRTG SPTAN1 NLGN3 NLGN4X EHD1 NLGN2 FGG PLEC HSPA1A FLNB ABI1 TNC NLGN4Y NLGN1 SLC6A4 SLC14A2 | 5.94e-04 | 599 | 209 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 3-kinase activity | 6.45e-04 | 4 | 209 | 2 | GO:0052724 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 1-kinase activity | 6.45e-04 | 4 | 209 | 2 | GO:0052723 | |
| GeneOntologyMolecularFunction | actin filament binding | 6.69e-04 | 227 | 209 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 7.93e-04 | 40 | 209 | 4 | GO:0140662 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 8.21e-04 | 18 | 209 | 3 | GO:0051787 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.21e-04 | 18 | 209 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 8.35e-04 | 70 | 209 | 5 | GO:0008235 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 1.05e-03 | 43 | 209 | 4 | GO:0004177 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 1.07e-03 | 5 | 209 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH6 MAP1B SPTA1 SPTAN1 EML6 CORO2B PTPRC PLEKHM2 KIF5A PLEC TRIM36 RAB27A RAB27B MAPK8IP1 DIP2B FLNB FLNC ABI1 CRK SLC6A4 KATNBL1 LMO7 MYO15A | 1.23e-03 | 1099 | 209 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.53e-03 | 118 | 209 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.59e-03 | 6 | 209 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.59e-03 | 6 | 209 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 1.67e-03 | 163 | 209 | 7 | GO:0031072 | |
| GeneOntologyMolecularFunction | ankyrin binding | 1.72e-03 | 23 | 209 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 2.13e-03 | 126 | 209 | 6 | GO:0051082 | |
| GeneOntologyMolecularFunction | neurotrophin TRKA receptor binding | 2.21e-03 | 7 | 209 | 2 | GO:0005168 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 7.20e-09 | 16 | 208 | 6 | GO:0007158 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 2.40e-08 | 10 | 208 | 5 | GO:0097105 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 4.37e-08 | 11 | 208 | 5 | GO:0097104 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.20e-07 | 13 | 208 | 5 | GO:0097090 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 4.57e-06 | 93 | 208 | 8 | GO:0099068 | |
| GeneOntologyBiologicalProcess | cell growth | MAP1B CDKL3 SLIT2 NLGN3 MINAR1 CDC73 ZNF418 HSPA1A HSPA1B IP6K2 DIP2B NPR1 FLT4 NEDD4L TNC PUM2 SEMA5A CRK EFNA5 DCLK1 | 5.71e-06 | 625 | 208 | 20 | GO:0016049 |
| GeneOntologyBiologicalProcess | regulation of cell growth | MAP1B CDKL3 SLIT2 MINAR1 CDC73 ZNF418 HSPA1A HSPA1B IP6K2 DIP2B NPR1 FLT4 NEDD4L TNC PUM2 SEMA5A CRK EFNA5 | 5.76e-06 | 519 | 208 | 18 | GO:0001558 |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 1.16e-05 | 76 | 208 | 7 | GO:0051703 | |
| GeneOntologyBiologicalProcess | regulation of growth | MYH6 AHI1 MAP1B CDKL3 SLIT2 C3 MINAR1 CDC73 ZNF418 HSPA1A HSPA1B IP6K2 DIP2B NPR1 FLT4 NEDD4L TNC PUM2 SEMA5A CRK SLC6A4 EFNA5 | 1.32e-05 | 777 | 208 | 22 | GO:0040008 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | AHI1 MAP1B ACHE CDKL3 SLIT2 NLGN3 EHD1 MINAR1 PLXNA2 PLXNB1 NOVA2 DIP2B NEDD4L OBSL1 PUM2 SEMA5A NLGN1 CRK EFNA5 | 1.51e-05 | 612 | 208 | 19 | GO:0010975 |
| GeneOntologyBiologicalProcess | synapse assembly | MAP1B ACHE SLIT2 NLGN3 NLGN4X NLGN2 PLXNB1 NLGN4Y NLGN1 CRK EFNA5 DCLK1 GABRA1 | 1.58e-05 | 308 | 208 | 13 | GO:0007416 |
| GeneOntologyBiologicalProcess | growth | MYH6 AHI1 MAP1B CDKL3 SLIT2 NLGN3 NLGN4X C3 MINAR1 CDC73 PLEC ZNF418 HSPA1A HSPA1B IP6K2 DIP2B NPR1 FLT4 NEDD4L RBBP6 TNC NLGN4Y POR PUM2 SEMA5A CRK SLC6A4 EFNA5 DCLK1 | 1.90e-05 | 1235 | 208 | 29 | GO:0040007 |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 2.09e-05 | 56 | 208 | 6 | GO:0001941 | |
| GeneOntologyBiologicalProcess | synapse organization | MAP1B ACHE SLIT2 NLGN3 NLGN4X C3 NLGN2 PLXNB1 CACNA1S DRP2 TNC NLGN4Y GRID1 ALS2 NLGN1 ARHGAP39 CRK EFNA5 DCLK1 GABRA1 | 2.16e-05 | 685 | 208 | 20 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | PRTG MAP1B ACHE UNC5B CDKL3 SLIT2 NLGN3 KIF5A TCTN1 PLXNA2 PLXNB1 NOVA2 DIP2B ABI1 NEDD4L OBSL1 SEMA5A ALS2 NLGN1 EFNA5 DCLK1 | 2.38e-05 | 748 | 208 | 21 | GO:0048667 |
| GeneOntologyBiologicalProcess | axon development | PRTG MAP1B ACHE UNC5B CDKL3 SLIT2 NLGN3 KIF5A TCTN1 PLXNA2 PLXNB1 NOVA2 DIP2B TNC PUM2 SEMA5A ALS2 EFNA5 DCLK1 | 2.91e-05 | 642 | 208 | 19 | GO:0061564 |
| GeneOntologyBiologicalProcess | heat acclimation | 3.43e-05 | 7 | 208 | 3 | GO:0010286 | |
| GeneOntologyBiologicalProcess | neuron projection development | PRTG AHI1 MAP1B ACHE UNC5B CDKL3 SLIT2 NLGN3 EHD1 MINAR1 NLGN2 KIF5A TCTN1 PLXNA2 PLXNB1 NOVA2 DIP2B FAT4 ABI1 NEDD4L TNC OBSL1 PUM2 SEMA5A ALS2 NLGN1 CRK EFNA5 DCLK1 | 3.93e-05 | 1285 | 208 | 29 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell junction organization | MAP1B ACHE SLIT2 NLGN3 CORO2B NLGN4X C3 NLGN2 PLEC PLEKHA7 PLXNB1 CACNA1S DRP2 NEDD4L TNC NLGN4Y GRID1 ALS2 NLGN1 ARHGAP39 CRK EFNA5 DCLK1 GABRA1 | 5.02e-05 | 974 | 208 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to synapse | 5.45e-05 | 8 | 208 | 3 | GO:1902474 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 5.45e-05 | 8 | 208 | 3 | GO:2000809 | |
| GeneOntologyBiologicalProcess | negative regulation of cell growth | CDKL3 SLIT2 MINAR1 ZNF418 HSPA1A HSPA1B IP6K2 DIP2B NPR1 SEMA5A | 6.10e-05 | 212 | 208 | 10 | GO:0030308 |
| GeneOntologyBiologicalProcess | axonogenesis | PRTG MAP1B ACHE UNC5B CDKL3 SLIT2 NLGN3 KIF5A TCTN1 PLXNA2 PLXNB1 NOVA2 DIP2B SEMA5A ALS2 EFNA5 DCLK1 | 6.47e-05 | 566 | 208 | 17 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | PRTG MAP1B ACHE UNC5B CDKL3 SLIT2 NLGN3 KIF5A TCTN1 PLXNA2 PLXNB1 NOVA2 DIP2B ABI1 NEDD4L OBSL1 SEMA5A ALS2 NLGN1 EFNA5 DCLK1 | 6.51e-05 | 802 | 208 | 21 | GO:0048812 |
| GeneOntologyBiologicalProcess | neuron development | PRTG AHI1 MAP1B ACHE UNC5B CDKL3 PRDM1 SLIT2 NLGN3 EHD1 C3 MINAR1 NLGN2 KIF5A TCTN1 PLXNA2 PLXNB1 NOVA2 DIP2B FAT4 ABI1 NEDD4L TNC OBSL1 PUM2 SEMA5A ALS2 NLGN1 CRK EFNA5 DCLK1 | 6.79e-05 | 1463 | 208 | 31 | GO:0048666 |
| GeneOntologyBiologicalProcess | terminal button organization | 8.12e-05 | 9 | 208 | 3 | GO:0072553 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | PRTG MAP1B ACHE UNC5B CDKL3 SLIT2 NLGN3 KIF5A TCTN1 PLXNA2 PLXNB1 NOVA2 DIP2B ABI1 NEDD4L OBSL1 SEMA5A ALS2 NLGN1 EFNA5 DCLK1 | 8.75e-05 | 819 | 208 | 21 | GO:0120039 |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 9.73e-05 | 46 | 208 | 5 | GO:0006458 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | PRTG MAP1B ACHE UNC5B CDKL3 SLIT2 NLGN3 KIF5A TCTN1 PLXNA2 PLXNB1 NOVA2 DIP2B ABI1 NEDD4L OBSL1 SEMA5A ALS2 NLGN1 EFNA5 DCLK1 | 9.85e-05 | 826 | 208 | 21 | GO:0048858 |
| GeneOntologyBiologicalProcess | social behavior | 1.02e-04 | 74 | 208 | 6 | GO:0035176 | |
| GeneOntologyBiologicalProcess | inositol metabolic process | 1.15e-04 | 10 | 208 | 3 | GO:0006020 | |
| GeneOntologyBiologicalProcess | negative regulation of growth | CDKL3 SLIT2 MINAR1 ZNF418 HSPA1A HSPA1B IP6K2 DIP2B NPR1 SEMA5A SLC6A4 | 1.49e-04 | 283 | 208 | 11 | GO:0045926 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.49e-04 | 192 | 208 | 9 | GO:0050770 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.59e-04 | 114 | 208 | 7 | GO:0050772 | |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 2.08e-04 | 12 | 208 | 3 | GO:0090084 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 2.08e-04 | 12 | 208 | 3 | GO:2000807 | |
| GeneOntologyBiologicalProcess | ossification involved in bone maturation | 2.24e-04 | 30 | 208 | 4 | GO:0043931 | |
| GeneOntologyBiologicalProcess | cell junction assembly | MAP1B ACHE SLIT2 NLGN3 CORO2B NLGN4X NLGN2 PLEC PLXNB1 NEDD4L NLGN4Y NLGN1 CRK EFNA5 DCLK1 GABRA1 | 2.25e-04 | 569 | 208 | 16 | GO:0034329 |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | MAP1B CDKL3 SLIT2 NLGN3 DIP2B NEDD4L TNC PUM2 SEMA5A EFNA5 DCLK1 | 2.39e-04 | 299 | 208 | 11 | GO:0060560 |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 2.41e-04 | 122 | 208 | 7 | GO:0061387 | |
| GeneOntologyBiologicalProcess | developmental cell growth | MAP1B CDKL3 SLIT2 NLGN3 ZNF418 DIP2B NEDD4L PUM2 SEMA5A EFNA5 DCLK1 | 2.53e-04 | 301 | 208 | 11 | GO:0048588 |
| GeneOntologyBiologicalProcess | polyol metabolic process | 2.54e-04 | 123 | 208 | 7 | GO:0019751 | |
| GeneOntologyBiologicalProcess | inositol phosphate biosynthetic process | 2.55e-04 | 31 | 208 | 4 | GO:0032958 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 3.02e-04 | 3 | 208 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | glycerol-3-phosphate biosynthetic process | 3.02e-04 | 3 | 208 | 2 | GO:0046167 | |
| GeneOntologyBiologicalProcess | bone maturation | 3.27e-04 | 33 | 208 | 4 | GO:0070977 | |
| GeneOntologyBiologicalProcess | inclusion body assembly | 3.27e-04 | 33 | 208 | 4 | GO:0070841 | |
| GeneOntologyBiologicalProcess | regulation of respiratory gaseous exchange by nervous system process | 3.39e-04 | 14 | 208 | 3 | GO:0002087 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | MAP1B ACHE CDKL3 SLIT2 NLGN3 NLGN2 MME PLXNA2 PLXNB1 OBSL1 SEMA5A NLGN1 EFNA5 | 3.41e-04 | 418 | 208 | 13 | GO:0051962 |
| GeneOntologyBiologicalProcess | presynapse assembly | 3.46e-04 | 60 | 208 | 5 | GO:0099054 | |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 4.12e-04 | 35 | 208 | 4 | GO:0051085 | |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 4.27e-04 | 96 | 208 | 6 | GO:0048488 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | PRTG MAP1B ACHE UNC5B SPTA1 CDKL3 SLIT2 NLGN3 KIF5A PLEC TCTN1 PLXNA2 PLXNB1 NOVA2 DIP2B FLNB ABI1 NEDD4L OBSL1 SEMA5A ALS2 NLGN1 CRK EFNA5 DCLK1 | 4.35e-04 | 1194 | 208 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | axon extension | 4.47e-04 | 135 | 208 | 7 | GO:0048675 | |
| GeneOntologyBiologicalProcess | membrane assembly | 4.68e-04 | 64 | 208 | 5 | GO:0071709 | |
| GeneOntologyBiologicalProcess | animal organ maturation | 5.11e-04 | 37 | 208 | 4 | GO:0048799 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide salvage | 5.14e-04 | 16 | 208 | 3 | GO:0106380 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | AHI1 MAP1B ACHE SYT9 ALKBH5 NLGN3 STAC2 FNDC1 CORO2B PLEKHM2 REEP6 EHD1 ASTN2 NLGN2 FGG FKBP1A DDX4 A1CF NEDD4L PUM2 NLGN1 SIRT4 CRK EFNA5 DCLK1 | 5.41e-04 | 1212 | 208 | 25 | GO:0060341 |
| GeneOntologyBiologicalProcess | negative regulation of axon extension | 5.67e-04 | 38 | 208 | 4 | GO:0030517 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 5.90e-04 | 102 | 208 | 6 | GO:0140238 | |
| GeneOntologyBiologicalProcess | nitrate metabolic process | 5.99e-04 | 4 | 208 | 2 | GO:0042126 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 5.99e-04 | 4 | 208 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | regulation of respiratory system process | 6.19e-04 | 17 | 208 | 3 | GO:0044065 | |
| GeneOntologyBiologicalProcess | dendrite development | MAP1B ACHE CDKL3 NLGN3 NLGN2 ABI1 NEDD4L OBSL1 NLGN1 CRK DCLK1 | 6.23e-04 | 335 | 208 | 11 | GO:0016358 |
| GeneOntologyBiologicalProcess | polyol biosynthetic process | 6.62e-04 | 69 | 208 | 5 | GO:0046173 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | AHI1 MAP1B ACHE SPTA1 CDKL3 SLIT2 NLGN3 C3 MINAR1 PLCG1 PLXNA2 PLXNB1 DIP2B NPR1 FLT4 NEDD4L OBSL1 PUM2 SEMA5A NLGN1 CRK ADAMTS12 EFNA5 | 6.70e-04 | 1090 | 208 | 23 | GO:0022603 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH6 HSP90B1 MAP1B SPTA1 SPTAN1 SLIT2 CORO2B PLEC HSPA1A HSPA1B FKBP1A WDR72 FLNC ABI1 ERO1A OBSL1 SEMA5A ADAMTS12 KATNBL1 MKX MYO15A | 7.05e-04 | 957 | 208 | 21 | GO:0097435 |
| GeneOntologyBiologicalProcess | response to yeast | 7.38e-04 | 18 | 208 | 3 | GO:0001878 | |
| GeneOntologyBiologicalProcess | synaptic vesicle localization | 7.54e-04 | 71 | 208 | 5 | GO:0097479 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 7.60e-04 | 41 | 208 | 4 | GO:0051084 | |
| GeneOntologyBiologicalProcess | membrane biogenesis | 8.56e-04 | 73 | 208 | 5 | GO:0044091 | |
| GeneOntologyBiologicalProcess | presynapse organization | 8.56e-04 | 73 | 208 | 5 | GO:0099172 | |
| GeneOntologyBiologicalProcess | purine nucleotide salvage | 8.69e-04 | 19 | 208 | 3 | GO:0032261 | |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 8.69e-04 | 19 | 208 | 3 | GO:0006957 | |
| GeneOntologyBiologicalProcess | protein folding | 9.11e-04 | 246 | 208 | 9 | GO:0006457 | |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling | 9.20e-04 | 111 | 208 | 6 | GO:0036465 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 9.26e-04 | 198 | 208 | 8 | GO:0048813 | |
| GeneOntologyBiologicalProcess | developmental growth | MYH6 MAP1B CDKL3 SLIT2 NLGN3 NLGN4X C3 PLEC ZNF418 DIP2B NEDD4L RBBP6 TNC NLGN4Y POR PUM2 SEMA5A SLC6A4 EFNA5 DCLK1 | 9.40e-04 | 911 | 208 | 20 | GO:0048589 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | AHI1 MAP1B ACHE CDKL3 SLIT2 NLGN3 EHD1 MINAR1 PLXNA2 PLXNB1 NOVA2 DIP2B NEDD4L OBSL1 PUM2 SEMA5A NLGN1 CRK EFNA5 | 9.68e-04 | 846 | 208 | 19 | GO:0120035 |
| GeneOntologyBiologicalProcess | alcohol biosynthetic process | 9.75e-04 | 154 | 208 | 7 | GO:0046165 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of gram-positive bacterium | 9.92e-04 | 5 | 208 | 2 | GO:0070946 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 9.95e-04 | 44 | 208 | 4 | GO:0098698 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 1.05e-03 | 202 | 208 | 8 | GO:0051963 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 1.05e-08 | 4 | 213 | 4 | GO:0098983 | |
| GeneOntologyCellularComponent | symmetric synapse | 6.97e-06 | 13 | 213 | 4 | GO:0032280 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.43e-05 | 31 | 213 | 5 | GO:0060077 | |
| GeneOntologyCellularComponent | dendrite | MAP1B ACHE SLIT2 NLGN3 NLGN4X SACS NLGN2 KIF5A MME PLEC RAB27A MAPK8IP1 DIP2B CACNA1S DRP2 NLGN4Y ERO1A PUM2 ALS2 NLGN1 NCF1C NCF1B GABRA1 | 2.37e-05 | 858 | 213 | 23 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | MAP1B ACHE SLIT2 NLGN3 NLGN4X SACS NLGN2 KIF5A MME PLEC RAB27A MAPK8IP1 DIP2B CACNA1S DRP2 NLGN4Y ERO1A PUM2 ALS2 NLGN1 NCF1C NCF1B GABRA1 | 2.46e-05 | 860 | 213 | 23 | GO:0097447 |
| GeneOntologyCellularComponent | secretory granule | IMPDH1 IMPDH2 SPTAN1 SYT9 HPSE PTPRC MAGED2 CT55 C3 ATP11A MME FGG TMX3 TRIM36 HSPA1A HSPA1B RAB27A RAB27B AMPD3 DMXL2 DSC1 CTSA RNPEP LTA4H LTF | 4.11e-05 | 1014 | 213 | 25 | GO:0030141 |
| GeneOntologyCellularComponent | somatodendritic compartment | PDE9A MAP1B ACHE SLIT2 NLGN3 NLGN4X SACS ASTN2 NLGN2 KIF5A MME PLEC RAB27A MAPK8IP1 DIP2B CACNA1S FLNB DRP2 NLGN4Y ERO1A PUM2 ALS2 APOB NLGN1 ENDOG NCF1C NCF1B GABRA1 | 5.50e-05 | 1228 | 213 | 28 | GO:0036477 |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 9.49e-05 | 24 | 213 | 4 | GO:0098985 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.19e-04 | 10 | 213 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | vesicle lumen | IMPDH1 IMPDH2 SPTAN1 HPSE MAGED2 C3 FGG RAB27A AMPD3 APOB CTSA LTF | 1.63e-04 | 332 | 213 | 12 | GO:0031983 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 2.86e-04 | 164 | 213 | 8 | GO:0098982 | |
| GeneOntologyCellularComponent | I band | 3.10e-04 | 166 | 213 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | secretory vesicle | IMPDH1 IMPDH2 SPTAN1 SYT9 HPSE PTPRC MAGED2 CT55 C3 ATP11A MME FGG TMX3 TRIM36 HSPA1A HSPA1B RAB27A RAB27B AMPD3 DMXL2 DSC1 SYT6 CTSA RNPEP LTA4H LTF | 4.14e-04 | 1246 | 213 | 26 | GO:0099503 |
| GeneOntologyCellularComponent | anchoring junction | HSP90B1 AHI1 SPTAN1 FNDC1 FAT2 CORO2B PTPRC MME PLCG1 PLEC PLEKHA7 HSPA1A HSPA1B FLNB FLNC DSC1 TNC OBSL1 SLC6A4 TGM1 EFNA5 LMO7 | 4.24e-04 | 976 | 213 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | secretory granule lumen | IMPDH1 IMPDH2 SPTAN1 HPSE MAGED2 C3 FGG RAB27A AMPD3 CTSA LTF | 5.29e-04 | 325 | 213 | 11 | GO:0034774 |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | IMPDH1 IMPDH2 SPTAN1 HPSE MAGED2 C3 FGG RAB27A AMPD3 CTSA LTF | 6.00e-04 | 330 | 213 | 11 | GO:0060205 |
| GeneOntologyCellularComponent | aggresome | 7.18e-04 | 40 | 213 | 4 | GO:0016235 | |
| GeneOntologyCellularComponent | Z disc | 9.24e-04 | 151 | 213 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | glycinergic synapse | 1.05e-03 | 20 | 213 | 3 | GO:0098690 | |
| GeneOntologyCellularComponent | cell body | PDE9A MAP1B ACHE SLIT2 NLGN3 ASTN2 KIF5A MME HSPA1B MAPK8IP1 DIP2B FLNB DRP2 PUM2 ALS2 APOB PITPNM1 ENDOG NCF1C NCF1B | 1.36e-03 | 929 | 213 | 20 | GO:0044297 |
| GeneOntologyCellularComponent | focal adhesion | HSP90B1 CORO2B PTPRC MME PLEC HSPA1A HSPA1B FLNB FLNC TNC SLC6A4 LMO7 | 1.63e-03 | 431 | 213 | 12 | GO:0005925 |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 1.72e-03 | 124 | 213 | 6 | GO:1904813 | |
| GeneOntologyCellularComponent | axon | PRTG MAP1B ACHE SPTA1 SPTAN1 SLIT2 SACS NLGN2 KIF5A MME PLEC FKBP1A RAB27B MAPK8IP1 DIP2B ABI1 ALS2 IL1R1 DCLK1 | 1.99e-03 | 891 | 213 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.03e-03 | 25 | 213 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | endocytic vesicle lumen | 2.03e-03 | 25 | 213 | 3 | GO:0071682 | |
| GeneOntologyCellularComponent | cell-substrate junction | HSP90B1 CORO2B PTPRC MME PLEC HSPA1A HSPA1B FLNB FLNC TNC SLC6A4 LMO7 | 2.05e-03 | 443 | 213 | 12 | GO:0030055 |
| GeneOntologyCellularComponent | hippocampal mossy fiber | 2.10e-03 | 7 | 213 | 2 | GO:0097457 | |
| GeneOntologyCellularComponent | neuronal cell body | PDE9A MAP1B ACHE SLIT2 NLGN3 ASTN2 KIF5A MME MAPK8IP1 DIP2B FLNB DRP2 PUM2 ALS2 APOB ENDOG NCF1C NCF1B | 2.32e-03 | 835 | 213 | 18 | GO:0043025 |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 2.94e-03 | 185 | 213 | 7 | GO:0101002 | |
| Domain | Nlgn | 1.71e-10 | 5 | 210 | 5 | IPR000460 | |
| Domain | Carboxylesterase_B_CS | 3.02e-09 | 13 | 210 | 6 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 5.24e-09 | 14 | 210 | 6 | PS00941 | |
| Domain | COesterase | 5.24e-09 | 14 | 210 | 6 | PF00135 | |
| Domain | CarbesteraseB | 5.24e-09 | 14 | 210 | 6 | IPR002018 | |
| Domain | SH3_1 | AHI1 SPTA1 SPTAN1 STAC2 PLCG1 MAPK8IP1 ABI1 ARHGAP10 CRK FUT8 | 1.70e-05 | 164 | 210 | 10 | PF00018 |
| Domain | SH3 | AHI1 SPTA1 SPTAN1 STAC2 PLCG1 MAPK8IP1 ABI1 ARHGAP10 CRK MYO15A FUT8 | 3.46e-05 | 216 | 210 | 11 | SM00326 |
| Domain | SH3 | AHI1 SPTA1 SPTAN1 STAC2 PLCG1 MAPK8IP1 ABI1 ARHGAP10 CRK MYO15A FUT8 | 3.46e-05 | 216 | 210 | 11 | PS50002 |
| Domain | SH3_domain | AHI1 SPTA1 SPTAN1 STAC2 PLCG1 MAPK8IP1 ABI1 ARHGAP10 CRK MYO15A FUT8 | 4.09e-05 | 220 | 210 | 11 | IPR001452 |
| Domain | - | 6.03e-05 | 119 | 210 | 8 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 6.03e-05 | 119 | 210 | 8 | IPR029058 | |
| Domain | NLGN4 | 1.26e-04 | 2 | 210 | 2 | IPR030025 | |
| Domain | IMP_DH | 1.26e-04 | 2 | 210 | 2 | IPR005990 | |
| Domain | Ig_E-set | 1.74e-04 | 104 | 210 | 7 | IPR014756 | |
| Domain | IPT | 2.23e-04 | 27 | 210 | 4 | SM00429 | |
| Domain | FN3 | 2.52e-04 | 185 | 210 | 9 | SM00060 | |
| Domain | Spectrin_repeat | 2.96e-04 | 29 | 210 | 4 | IPR002017 | |
| Domain | Carb_kinase_FGGY_CS | 3.75e-04 | 3 | 210 | 2 | IPR018483 | |
| Domain | TIG | 3.85e-04 | 31 | 210 | 4 | PF01833 | |
| Domain | IPT | 4.36e-04 | 32 | 210 | 4 | IPR002909 | |
| Domain | SPEC | 4.36e-04 | 32 | 210 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 4.36e-04 | 32 | 210 | 4 | IPR018159 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.65e-04 | 14 | 210 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 4.65e-04 | 14 | 210 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.65e-04 | 14 | 210 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.65e-04 | 14 | 210 | 3 | IPR011704 | |
| Domain | AAA_8 | 4.65e-04 | 14 | 210 | 3 | PF12780 | |
| Domain | AAA_5 | 4.65e-04 | 14 | 210 | 3 | PF07728 | |
| Domain | - | PRTG UNC5B FNDC1 PTPRC ASTN2 TRIM36 PLXNA2 PLXNB1 FNDC3B FLNB FLNC FLT4 TNC OBSL1 RELB PKHD1L1 TGM1 IL1R1 | 5.20e-04 | 663 | 210 | 18 | 2.60.40.10 |
| Domain | DHC_fam | 5.77e-04 | 15 | 210 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 5.77e-04 | 15 | 210 | 3 | PF03028 | |
| Domain | Spectrin_alpha_SH3 | 5.77e-04 | 15 | 210 | 3 | IPR013315 | |
| Domain | Dynein_heavy_dom | 5.77e-04 | 15 | 210 | 3 | IPR004273 | |
| Domain | FN3_dom | 6.15e-04 | 209 | 210 | 9 | IPR003961 | |
| Domain | TSP_1 | 7.09e-04 | 63 | 210 | 5 | PF00090 | |
| Domain | IMPDH | 7.44e-04 | 4 | 210 | 2 | PF00478 | |
| Domain | LRRC37AB_C | 7.44e-04 | 4 | 210 | 2 | IPR029423 | |
| Domain | IMP_DH_GMPRt | 7.44e-04 | 4 | 210 | 2 | IPR001093 | |
| Domain | Peptidase_M1_C | 7.44e-04 | 4 | 210 | 2 | IPR015211 | |
| Domain | IMP_DH_GMP_RED | 7.44e-04 | 4 | 210 | 2 | PS00487 | |
| Domain | Leuk-A4-hydro_C | 7.44e-04 | 4 | 210 | 2 | SM01263 | |
| Domain | IMP_DH/GMP_Rdtase_CS | 7.44e-04 | 4 | 210 | 2 | IPR015875 | |
| Domain | LRRC37AB_C | 7.44e-04 | 4 | 210 | 2 | PF14914 | |
| Domain | Leuk-A4-hydro_C | 7.44e-04 | 4 | 210 | 2 | PF09127 | |
| Domain | LRRC37_N | 7.44e-04 | 4 | 210 | 2 | IPR032754 | |
| Domain | LRRC37 | 7.44e-04 | 4 | 210 | 2 | PF15779 | |
| Domain | Glycerol_kin | 7.44e-04 | 4 | 210 | 2 | IPR005999 | |
| Domain | LRRC37A/B-like | 7.44e-04 | 4 | 210 | 2 | IPR015753 | |
| Domain | TSP1 | 8.19e-04 | 65 | 210 | 5 | SM00209 | |
| Domain | TSP1_rpt | 8.19e-04 | 65 | 210 | 5 | IPR000884 | |
| Domain | TSP1 | 8.19e-04 | 65 | 210 | 5 | PS50092 | |
| Domain | Ig-like_fold | PRTG UNC5B FNDC1 PTPRC ASTN2 TRIM36 PLXNA2 PLXNB1 FNDC3B FLNB FLNC FLT4 TNC OBSL1 RELB PKHD1L1 TGM1 IL1R1 | 1.07e-03 | 706 | 210 | 18 | IPR013783 |
| Domain | FGGY_KINASES_1 | 1.23e-03 | 5 | 210 | 2 | PS00933 | |
| Domain | Carb_kinase_FGGY_C | 1.23e-03 | 5 | 210 | 2 | IPR018485 | |
| Domain | FGGY_KINASES_2 | 1.23e-03 | 5 | 210 | 2 | PS00445 | |
| Domain | LamG | 1.48e-03 | 44 | 210 | 4 | SM00282 | |
| Domain | Tudor-knot | 1.83e-03 | 6 | 210 | 2 | PF11717 | |
| Domain | Carb_kinase_FGGY_N | 1.83e-03 | 6 | 210 | 2 | IPR018484 | |
| Domain | EFhand_Ca_insen | 1.83e-03 | 6 | 210 | 2 | PF08726 | |
| Domain | Tudor-knot | 1.83e-03 | 6 | 210 | 2 | IPR025995 | |
| Domain | Acid_Pase_AS | 1.83e-03 | 6 | 210 | 2 | IPR033379 | |
| Domain | EF-hand_Ca_insen | 1.83e-03 | 6 | 210 | 2 | IPR014837 | |
| Domain | FGGY_C | 1.83e-03 | 6 | 210 | 2 | PF02782 | |
| Domain | Cupredoxin | 1.84e-03 | 22 | 210 | 3 | IPR008972 | |
| Domain | FN3 | 1.90e-03 | 199 | 210 | 8 | PS50853 | |
| Domain | WW | 1.90e-03 | 47 | 210 | 4 | PF00397 | |
| Domain | WW | 2.05e-03 | 48 | 210 | 4 | SM00456 | |
| Domain | Spectrin | 2.10e-03 | 23 | 210 | 3 | PF00435 | |
| Domain | ACTININ_2 | 2.10e-03 | 23 | 210 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.10e-03 | 23 | 210 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.10e-03 | 23 | 210 | 3 | IPR001589 | |
| Domain | DNAJ_1 | 2.22e-03 | 49 | 210 | 4 | PS00636 | |
| Domain | DNAJ_2 | 2.22e-03 | 49 | 210 | 4 | PS50076 | |
| Domain | DnaJ | 2.22e-03 | 49 | 210 | 4 | SM00271 | |
| Domain | - | 2.22e-03 | 49 | 210 | 4 | 1.10.287.110 | |
| Domain | fn3 | 2.41e-03 | 162 | 210 | 7 | PF00041 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 2.55e-03 | 7 | 210 | 2 | PS00778 | |
| Domain | Carb_kinase_FGGY | 2.55e-03 | 7 | 210 | 2 | IPR000577 | |
| Domain | FGGY_N | 2.55e-03 | 7 | 210 | 2 | PF00370 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 2.55e-03 | 7 | 210 | 2 | PS00616 | |
| Domain | DnaJ_domain | 2.57e-03 | 51 | 210 | 4 | IPR001623 | |
| Domain | WW_DOMAIN_1 | 2.57e-03 | 51 | 210 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 2.57e-03 | 51 | 210 | 4 | PS50020 | |
| Domain | WW_dom | 2.76e-03 | 52 | 210 | 4 | IPR001202 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | HSP90B1 IMPDH1 IMPDH2 SPTAN1 IRAK1 HPSE CFB PTPRC C3 ATP11A MME PLCG1 FGG C9 HSPA1A HSPA1B RAB27A AMPD3 ABI1 DSC1 PELI1 APOB RELB CTSA CRK LTA4H LTF NCF1C CTSK NCF1B | 1.22e-06 | 995 | 164 | 30 | MM14661 |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 3.13e-05 | 32 | 164 | 5 | MM15326 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 4.54e-05 | 56 | 164 | 6 | M27616 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 4.76e-05 | 18 | 164 | 4 | M48098 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | HSP90B1 IMPDH1 IMPDH2 SPTAN1 IRAK1 HPSE CFB PTPRC C3 ATP11A MME PLCG1 FGG C9 HSPA1A HSPA1B RAB27A AMPD3 ABI1 DSC1 PELI1 APOB RELB CTSA CRK LTA4H LTF CTSK | 1.02e-04 | 1128 | 164 | 28 | M1036 |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 1.23e-04 | 9 | 164 | 3 | M22072 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | IMPDH1 IMPDH2 SPTAN1 HPSE PTPRC C3 ATP11A MME HSPA1A HSPA1B RAB27A AMPD3 DSC1 CTSA LTA4H LTF | 1.45e-04 | 478 | 164 | 16 | M27620 |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 2.29e-04 | 48 | 164 | 5 | M26964 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 2.29e-04 | 48 | 164 | 5 | MM14589 | |
| Pubmed | RPL27A MYH6 HSP90B1 MAP1B SPTA1 SPTAN1 MATR3 PABPC4 NLGN3 CORO2B SACS EHD1 UQCRC2 FGG PLEC PLEKHA7 HSPA1A HSPA1B MAPK8IP1 FLNB FLNC DMXL2 ABI1 NEDD4L TNC IARS1 POR ARHGAP39 PLEKHA6 PITPNM1 TGM1 ZC2HC1A RNPEP LMO7 DCLK1 | 4.20e-12 | 1431 | 216 | 35 | 37142655 | |
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 8.82e-12 | 5 | 216 | 5 | 10996085 | |
| Pubmed | 8.82e-12 | 5 | 216 | 5 | 37865312 | ||
| Pubmed | 5.27e-11 | 6 | 216 | 5 | 21838267 | ||
| Pubmed | 5.27e-11 | 6 | 216 | 5 | 29724786 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 4.87e-10 | 8 | 216 | 5 | 30871858 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | HSP90B1 IMPDH2 MAP1B SPTAN1 CLPX SUPT5H C3 PLCG1 PLEC HSPA1A HSPA1B DIP2B FLNB FLNC IARS1 PRPF8 | 6.03e-10 | 344 | 216 | 16 | 30333137 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | RPL27A HSP90B1 IMPDH2 SPTAN1 MATR3 PABPC4 IRAK1 MAGED2 UQCRC2 PLEC HSPA1A FLNB FLNC DSC1 IARS1 PRPF8 RNPEP LMO7 | 1.40e-09 | 477 | 216 | 18 | 31300519 |
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 1.45e-09 | 4 | 216 | 4 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 1.45e-09 | 4 | 216 | 4 | 22671294 | |
| Pubmed | 1.45e-09 | 4 | 216 | 4 | 16077734 | ||
| Pubmed | 3.95e-09 | 11 | 216 | 5 | 26403076 | ||
| Pubmed | 3.95e-09 | 11 | 216 | 5 | 32973045 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL27A HSP90B1 DENND4A IMPDH2 SPTAN1 MATR3 PABPC4 CLPX NEK9 MAGED2 SUPT5H GNL2 PLCG1 CDC73 UQCRC2 MED23 PLEKHA7 HSPA1A SLC25A24 FLNB DSC1 IARS1 POLD1 ERO1A POLRMT POR APOB PRPF8 RNPEP LTF | 5.56e-09 | 1425 | 216 | 30 | 30948266 |
| Pubmed | CEP104 MAP1B SPTAN1 SACS NLGN2 PLEC DMXL2 ABI1 NEDD4L TNC ARHGAP39 PLEKHA6 PITPNM1 DCLK1 GABRA1 | 5.67e-09 | 347 | 216 | 15 | 17114649 | |
| Pubmed | Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. | 7.20e-09 | 5 | 216 | 4 | 15620359 | |
| Pubmed | CEP104 RPL27A MYH6 HSP90B1 DENND4A MAP1B SPTA1 SPTAN1 MATR3 PABPC4 EML6 CLPX MAGED2 SACS ATP11A KIF5A UQCRC2 PLEC PPIP5K2 PLXNA2 FLNB FLNC KDM5A DNAH2 APOB PRPF8 ADAMTS12 PHF20L1 LMO7 IL1R1 | 7.27e-09 | 1442 | 216 | 30 | 35575683 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RPL27A HSP90B1 IMPDH2 MAP1B SPTAN1 MATR3 SACS SUPT5H GNL2 UQCRC2 PLEC PPIP5K2 MED23 PLXNB1 SLC25A24 DIP2B FLNC DMXL2 NEDD4L KDM5A RBBP6 ARHGAP39 PRPF8 ZC2HC1A MKX | 1.96e-08 | 1082 | 216 | 25 | 38697112 |
| Pubmed | 2.15e-08 | 6 | 216 | 4 | 29742426 | ||
| Pubmed | 2.52e-08 | 15 | 216 | 5 | 18227507 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL27A HSP90B1 SPTAN1 MATR3 PABPC4 CDK11A MAGED2 GNL2 C3 UQCRC2 PLEC HSPA1A HSPA1B FLNB DSC1 RBBP6 IARS1 OBSL1 APOB PRPF8 TGM1 LMO7 LTF | 3.19e-08 | 949 | 216 | 23 | 36574265 |
| Pubmed | Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. | 1.25e-07 | 38 | 216 | 6 | 16263699 | |
| Pubmed | RPL27A HSP90B1 HIVEP2 PDE9A SPTAN1 DNAJB9 CORO2B SACS SUPT5H MLLT3 ASTN2 KIF5A PLCG1 PLEC HSPA1A HSPA1B MAPK8IP1 FLNB DMXL2 KDM5A OBSL1 PRPF8 LMO7 FUT8 TRIM37 DCLK1 | 1.38e-07 | 1285 | 216 | 26 | 35914814 | |
| Pubmed | HSP90B1 IMPDH2 MAP1B PTPRC TMX3 HSPA1A ERO1A POR ERGIC1 FUT8 | 1.38e-07 | 172 | 216 | 10 | 27375898 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH6 HSP90B1 IMPDH2 MAP1B SPTAN1 PABPC4 EHD1 C3 UQCRC2 PLEC HSPA1A HSPA1B SLC25A24 FLNB DSC1 IARS1 LMO7 LTF | 1.46e-07 | 647 | 216 | 18 | 26618866 |
| Pubmed | HSP90B1 SPTAN1 MATR3 PABPC4 PLEC PLEKHA7 HSPA1A FLNB RBBP6 POLRMT PUM2 LMO7 | 1.71e-07 | 274 | 216 | 12 | 34244482 | |
| Pubmed | 1.78e-07 | 9 | 216 | 4 | 9278515 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MATR3 IRAK1 SUPT5H NID1 C3 KIF5A PLCG1 CDC73 UQCRC2 TMX3 DIP2B FLNB FLNC ARHGAP10 POLD1 ERO1A POLRMT OBSL1 PRPF8 SLC6A4 BABAM1 FUT8 | 2.16e-07 | 974 | 216 | 22 | 28675297 |
| Pubmed | IMPDH1 IMPDH2 PABPC4 CDK11A SSBP3 UBN2 ALKBH5 KAT8 GNL2 LSM11 UQCRC2 MED23 PLEKHA7 SLC25A24 FNDC3B ABI1 KDM5A RBBP6 ARHGAP10 POLD1 ZNF652 POLRMT PUM2 ARHGAP39 ERGIC1 BABAM1 FUT8 DCLK1 | 2.18e-07 | 1497 | 216 | 28 | 31527615 | |
| Pubmed | Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits. | 2.36e-07 | 3 | 216 | 3 | 29100073 | |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 26291161 | ||
| Pubmed | Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses. | 2.36e-07 | 3 | 216 | 3 | 17897391 | |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 28607166 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 16982420 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 32011705 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 27217145 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 18628683 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 2.36e-07 | 3 | 216 | 3 | 21282647 | |
| Pubmed | HSP90B1 IMPDH2 MAP1B SPTAN1 MATR3 PABPC4 CLPX NEK9 LSM11 CDC73 PLEC HSPA1A FLNB FLNC IARS1 PRPF8 | 4.20e-07 | 551 | 216 | 16 | 34728620 | |
| Pubmed | 4.65e-07 | 47 | 216 | 6 | 35462405 | ||
| Pubmed | HSP90B1 SPTAN1 MATR3 MAGED2 CDC73 PLEC PPIP5K2 HSPA1B FLNB FLNC IARS1 ERO1A LMO7 | 4.74e-07 | 360 | 216 | 13 | 33111431 | |
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 5.22e-07 | 26 | 216 | 5 | 34848499 | |
| Pubmed | RPL27A HSP90B1 IMPDH2 SPTAN1 MATR3 PABPC4 EHD1 C3 UQCRC2 PLEC C9 HSPA1B FLNB IARS1 PRPF8 ERGIC1 LMO7 LTF | 5.77e-07 | 711 | 216 | 18 | 33022573 | |
| Pubmed | RPL27A HSP90B1 IMPDH1 IMPDH2 SPTAN1 REEP6 GNL2 PLEC MED23 FLNB TNC ERO1A ZNF503 LMO7 LTA4H | 7.00e-07 | 503 | 216 | 15 | 36217030 | |
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 30056576 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 9593709 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 32719346 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 20579107 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 17292328 | ||
| Pubmed | 1.08e-06 | 54 | 216 | 6 | 35391932 | ||
| Pubmed | 1.31e-06 | 31 | 216 | 5 | 38395995 | ||
| Pubmed | Translational animal models of autism and neurodevelopmental disorders. | 1.38e-06 | 14 | 216 | 4 | 23226954 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RPL27A HSP90B1 IMPDH1 IMPDH2 SPTAN1 PABPC4 NEK9 MAGED2 SUPT5H EHD1 PLCG1 CDC73 PLEC HSPA1A CACNA1S FLNB FLNC IARS1 POLD1 ERO1A ARMC9 DPP3 CTSA ZNF503 BABAM1 NT5C2 | 1.43e-06 | 1455 | 216 | 26 | 22863883 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SLIT2 GK GK2 EHD1 NID1 MLLT3 MME FGG C9 PLEKHA7 RAB27A FLNB ABI1 GRID1 ARMC9 XPNPEP2 CTSA CRK RNPEP LTA4H MYO15A | 1.70e-06 | 1016 | 216 | 21 | 19056867 |
| Pubmed | 1.81e-06 | 92 | 216 | 7 | 37343697 | ||
| Pubmed | HSP90B1 IMPDH2 SPTAN1 PABPC4 CLPX ALKBH5 C3 ATP11A UQCRC2 TMX3 HSPA1B FLNB NEDD4L RBBP6 IARS1 ERO1A POLRMT APOB RELB PRPF8 CTSA ERGIC1 RNPEP NT5C2 | 2.07e-06 | 1297 | 216 | 24 | 33545068 | |
| Pubmed | 2.09e-06 | 94 | 216 | 7 | 35122331 | ||
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 28939043 | ||
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 3027087 | ||
| Pubmed | TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase. | 2.34e-06 | 5 | 216 | 3 | 15885686 | |
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 11568360 | ||
| Pubmed | 5-HT modulation of a medial septal circuit tunes social memory stability. | 2.34e-06 | 5 | 216 | 3 | 34616037 | |
| Pubmed | Neuroligins Are Selectively Essential for NMDAR Signaling in Cerebellar Stellate Interneurons. | 2.34e-06 | 5 | 216 | 3 | 27581450 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | RPL27A HSP90B1 IMPDH2 MAP1B SPTAN1 MATR3 PABPC4 CORO2B MAGED2 UQCRC2 HSPA1A HSPA1B DCAF15 IARS1 PUM2 PRPF8 LTA4H | 2.74e-06 | 714 | 216 | 17 | 28302793 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DENND4A AHI1 PDE9A CDK11A NEK9 SLIT2 MAGED2 SUPT5H C3 UQCRC2 PLEC PPIP5K2 PLEKHA7 TCTN1 ABI1 ARHGAP10 IARS1 POLD1 OBSL1 PRPF8 CTSA ERGIC1 LMO7 DCLK1 | 2.83e-06 | 1321 | 216 | 24 | 27173435 |
| Pubmed | IMPDH2 SPTAN1 MATR3 UBN2 NEK9 NLGN3 MAGED2 NLGN2 KIF5A CDC73 MAPK8IP1 DIP2B DMXL2 ABI1 NEDD4L KDM5A ARHGAP39 ZC2HC1A NT5C2 DCLK1 | 2.83e-06 | 963 | 216 | 20 | 28671696 | |
| Pubmed | UBN2 NEK9 NLGN3 FAT2 SACS ASTN2 ATP11A MINAR1 NLGN2 DMXL2 ARHGAP39 PLEKHA6 ERGIC1 REXO1L1P | 2.92e-06 | 493 | 216 | 14 | 15368895 | |
| Pubmed | RPL27A IMPDH2 SPTAN1 MATR3 PABPC4 IRAK1 CDK11A MECOM CLPX SSBP3 UBN2 PRDM1 MAGED2 KAT8 GNL2 UQCRC2 ARID4A KDM5A RBBP6 IARS1 PUM2 RELB FIGN ZNF503 NT5C2 | 3.36e-06 | 1429 | 216 | 25 | 35140242 | |
| Pubmed | 3.38e-06 | 191 | 216 | 9 | 33762435 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CFB EHD1 NID1 C3 MME FGG C9 HSPA1A HSPA1B RAB27A RAB27B FLNB FAT4 DSC1 NEDD4L SEMA5A APOB CTSA RNPEP LTA4H LTF | 3.81e-06 | 1070 | 216 | 21 | 23533145 |
| Pubmed | HSP90B1 IMPDH2 MAP1B SPTAN1 PABPC4 IRAK1 CLPX SSBP3 UBN2 HPSE EHD1 GNL2 UQCRC2 TMX3 RAB27A FLNB POLD1 ERO1A POLRMT RELB PRPF8 CTSA LMO7 MKX LTF | 3.84e-06 | 1440 | 216 | 25 | 30833792 | |
| Pubmed | IRAK1 CFB MAGED2 FGG PPIP5K2 RAB27A FLNB ABI1 FBXW9 ERO1A PRPF8 LMO7 | 4.09e-06 | 371 | 216 | 12 | 15747579 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 4.14e-06 | 18 | 216 | 4 | 12119179 | |
| Pubmed | IgSF21 promotes differentiation of inhibitory synapses via binding to neurexin2α. | 4.14e-06 | 18 | 216 | 4 | 28864826 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL27A HSP90B1 IMPDH2 MAP1B SPTAN1 MATR3 CLPX NEK9 MAGED2 EHD1 PLCG1 UQCRC2 PLEC FNDC3B FLNB FLNC DSC1 IARS1 POLD1 POLRMT PRPF8 TGM1 ZC2HC1A LTF | 4.24e-06 | 1353 | 216 | 24 | 29467282 |
| Pubmed | Hsp90 directly modulates the spatial distribution of AF9/MLLT3 and affects target gene expression. | 4.66e-06 | 6 | 216 | 3 | 20159978 | |
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 4.66e-06 | 6 | 216 | 3 | 8576240 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | RPL27A HSP90B1 IMPDH2 MAP1B SPTAN1 MATR3 HSPA1A IARS1 POLD1 PRPF8 | 5.13e-06 | 256 | 216 | 10 | 32698014 |
| Pubmed | 5.31e-06 | 257 | 216 | 10 | 16335952 | ||
| Pubmed | MAP1B SPTAN1 CDC73 UQCRC2 HSPA1A FLNB DSC1 IARS1 POR NT5C2 LTF | 5.85e-06 | 320 | 216 | 11 | 28685749 | |
| Pubmed | 6.22e-06 | 42 | 216 | 5 | 21909110 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RPL27A HSP90B1 SPTAN1 MATR3 PABPC4 MAGED2 KIF5A UQCRC2 PLEC HSPA1A HSPA1B FLNB FLNC DNAH3 ABI1 IARS1 DNAH2 PRPF8 | 6.65e-06 | 847 | 216 | 18 | 35235311 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPL27A HSP90B1 IMPDH2 MAP1B MATR3 PABPC4 IRAK1 SLIT2 SACS SUPT5H GNL2 UQCRC2 PLEC FLNB FLNC NEDD4L IARS1 OBSL1 PRPF8 LMO7 | 7.03e-06 | 1024 | 216 | 20 | 24711643 |
| Pubmed | RPL27A HSP90B1 PABPC4 C3 UQCRC2 FLNB IARS1 ERO1A PRPF8 TGM1 LTF | 7.17e-06 | 327 | 216 | 11 | 31409639 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MAP1B CDK11A MECOM GK NOVA2 FLNC ABI1 ARID4A KDM5A ARHGAP10 IARS1 POLRMT OBSL1 RELB PRPF8 TGM1 PHF20L1 SETD7 | 7.80e-06 | 857 | 216 | 18 | 25609649 |
| Pubmed | 8.12e-06 | 7 | 216 | 3 | 12496252 | ||
| Pubmed | Killing activity of neutrophils is mediated through activation of proteases by K+ flux. | 8.12e-06 | 7 | 216 | 3 | 11907569 | |
| Pubmed | 8.12e-06 | 7 | 216 | 3 | 9256245 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | IMPDH2 SPTAN1 SUPT5H PLEC HSPA1A DIP2B FLNB IARS1 POLD1 PRPF8 LMO7 | 8.27e-06 | 332 | 216 | 11 | 32786267 |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | RPL27A HSP90B1 PABPC4 MAGED2 UQCRC2 ABI1 IARS1 POLD1 POLRMT PRPF8 | 8.72e-06 | 272 | 216 | 10 | 25315684 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL27A HSP90B1 IMPDH2 MAP1B SPTAN1 MATR3 PABPC4 NEK9 MAGED2 PLEC HSPA1A FKBP1A FLNB FLNC ABI1 IARS1 POLD1 PRPF8 RNPEP LMO7 LTA4H | 1.12e-05 | 1149 | 216 | 21 | 35446349 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | SPTAN1 NLGN3 NLGN4X SACS DMXL2 NLGN4Y NLGN1 ARHGAP39 PITPNM1 DCLK1 | 1.16e-05 | 281 | 216 | 10 | 28706196 |
| Pubmed | The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. | 1.17e-05 | 23 | 216 | 4 | 21231916 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | RPL27A IMPDH2 MAP1B SPTAN1 MATR3 PABPC4 MAGED2 PLEC HSPA1B FLNC DSC1 IARS1 TGM1 LTF | 1.19e-05 | 558 | 216 | 14 | 27591049 |
| Pubmed | Control of excitatory and inhibitory synapse formation by neuroligins. | 1.29e-05 | 8 | 216 | 3 | 15681343 | |
| Pubmed | 1.29e-05 | 8 | 216 | 3 | 26367131 | ||
| Pubmed | HSP90B1 DNAJB9 FAT2 EHD1 PLEC HSPA1A HSPA1B RAB27B TGM1 RNPEP LTF FUT8 | 1.32e-05 | 417 | 216 | 12 | 19199708 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL27A HSP90B1 IMPDH2 SPTAN1 MATR3 PABPC4 MAGED2 GNL2 C3 UQCRC2 PLEC C9 HSPA1B SLC25A24 FLNB DSC1 RBBP6 IARS1 POLRMT PRPF8 LMO7 LTF | 1.34e-05 | 1257 | 216 | 22 | 36526897 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RPL27A HSP90B1 GALNT1 MATR3 CDK11A DNAJB9 CLPX SLIT2 PTPRC REEP6 NID1 UQCRC2 PLEC SLC25A24 FNDC3B FLNB FLNC ERO1A POR PRPF8 CTSA ERGIC1 NT5C2 FUT8 | 1.35e-05 | 1451 | 216 | 24 | 30550785 |
| Pubmed | CCDC71L MAP1B SPTAN1 CDK11A MECOM UBN2 NEK9 KAT8 C3 KIF5A MED23 FKBP1A FLNB ARID4A ZNF503 | 1.41e-05 | 645 | 216 | 15 | 25281560 | |
| Interaction | PINK1 interactions | RPL27A HSP90B1 IMPDH2 MAP1B SPTAN1 MATR3 PABPC4 IRAK1 MAGED2 C3 UQCRC2 FGG PLEC HSPA1A HSPA1B FLNB FLNC DSC1 NEDD4L IARS1 POR PRPF8 TGM1 RNPEP LMO7 | 5.15e-08 | 679 | 211 | 25 | int:PINK1 |
| Interaction | NLGN3 interactions | 9.77e-07 | 99 | 211 | 9 | int:NLGN3 | |
| Interaction | KCTD13 interactions | RPL27A MYH6 HSP90B1 MAP1B SPTA1 SPTAN1 MATR3 PABPC4 NLGN3 CORO2B SACS EHD1 UQCRC2 FGG PLEC PLEKHA7 HSPA1A MAPK8IP1 FLNB FLNC DMXL2 ABI1 NEDD4L TNC IARS1 POR ARHGAP39 PLEKHA6 CRK PITPNM1 TGM1 ZC2HC1A RNPEP LMO7 DCLK1 | 1.20e-06 | 1394 | 211 | 35 | int:KCTD13 |
| Interaction | ITGB3 interactions | HSP90B1 MAP1B SPTAN1 SUPT5H NID1 FGG PLEC FLNB FLNC IARS1 PRPF8 | 1.84e-06 | 170 | 211 | 11 | int:ITGB3 |
| Interaction | HSPB1 interactions | MAP1B MATR3 PABPC4 CDKL3 IRAK1 MECOM SUPT5H EHD1 MME CDC73 UQCRC2 HSPA1A FNDC3B FLNB ABI1 POLD1 OBSL1 PRPF8 CRK TGM1 PDIK1L TRIM37 | 5.57e-06 | 708 | 211 | 22 | int:HSPB1 |
| Interaction | HSP90AB1 interactions | HSP90B1 AHI1 MAP1B SPTAN1 IRAK1 CDK11A MAGED2 PLCG1 CDC73 UQCRC2 HSPA1A IP6K2 DMXL2 FLT4 FKBP6 ERO1A DNAH2 OBSL1 PLEKHA6 PRPF8 CRK SLC6A4 PDIK1L MYO15A TRIM37 GABRA1 | 8.94e-06 | 960 | 211 | 26 | int:HSP90AB1 |
| Interaction | PPIB interactions | HSP90B1 MAP1B DNAJB9 FKBP1A TCTN1 FLNC ISYNA1 OBSL1 APOB ARHGAP39 PRPF8 SLC6A4 ERGIC1 TRIM37 | 1.76e-05 | 345 | 211 | 14 | int:PPIB |
| Interaction | HSP90AA1 interactions | HSP90B1 AHI1 MAP1B SPTAN1 PABPC4 IRAK1 CDK11A NEK9 CFB PRDM1 KLHL29 MAGED2 SUPT5H C3 CDC73 UQCRC2 TRIM36 HSPA1A HSPA1B FKBP1A IP6K2 FLT4 FKBP6 APOB HEATR5A PRPF8 PDIK1L MKX TRIM37 GABRA1 | 2.22e-05 | 1263 | 211 | 30 | int:HSP90AA1 |
| Interaction | SCARB2 interactions | IMPDH2 SPTAN1 GNL2 HSPA1A RAB27B FLNB SYT6 POLRMT PRPF8 LMO7 | 4.13e-05 | 195 | 211 | 10 | int:SCARB2 |
| Interaction | TNIK interactions | SPTAN1 MATR3 UBN2 MAGED2 NLGN2 KIF5A CDC73 HSPA1A ABI1 NEDD4L ERO1A ARHGAP39 SLC6A4 DCLK1 | 5.20e-05 | 381 | 211 | 14 | int:TNIK |
| Interaction | NRXN1 interactions | 5.84e-05 | 127 | 211 | 8 | int:NRXN1 | |
| GeneFamily | Dyneins, axonemal | 3.36e-04 | 17 | 148 | 3 | 536 | |
| GeneFamily | Fibronectin type III domain containing | 3.51e-04 | 160 | 148 | 7 | 555 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 6.86e-04 | 49 | 148 | 4 | 584 | |
| GeneFamily | Glycerol kinases | 9.77e-04 | 6 | 148 | 2 | 568 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.36e-03 | 7 | 148 | 2 | 1113 | |
| GeneFamily | Plexins | 2.31e-03 | 9 | 148 | 2 | 683 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | HSP90B1 GALNT1 MAP1B PRKD3 NID1 FKBP1A PLXNA2 NOVA2 FLNB NPR1 FLT4 BSDC1 PELI1 IL1R1 | 2.46e-07 | 304 | 215 | 14 | M39113 |
| Coexpression | HELLER_SILENCED_BY_METHYLATION_DN | 2.92e-06 | 107 | 215 | 8 | M3185 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | CYP4B1 UNC5B CFB NLGN3 FNDC1 C3 ATP11A PLEC PLEKHA7 PLXNA2 PLXNB1 FLNB FLNC NPR1 NEDD4L FBXW9 OBSL1 ARMC9 DPP3 PKHD1L1 TGM1 LMO7 IL1R1 | 4.21e-06 | 955 | 215 | 23 | M45680 |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN | CCDC71L EML6 GK MAGED2 FKBP1A FLNB ABI1 KATNBL1 SLC10A1 CTSK | 6.48e-06 | 200 | 215 | 10 | M3742 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP2 CYP4B1 PRDM1 PTPRC NID1 MME CDC73 PPIP5K2 MED23 HSPA1A HSPA1B FNDC3B ARID4A RBBP6 PUM2 SEMA5A HEATR5A CRK PHF20L1 LMO7 SETD7 | 8.24e-06 | 854 | 215 | 21 | M1533 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP2 GALK2 GALNT1 MAP1B MECOM SLIT2 SACS PPIP5K2 SLC25A24 FLNB DMXL2 ABI1 ARID4A KDM5A PUM2 SEMA5A EFNA5 NT5C2 IL1R1 FUT8 TRIM37 | 8.53e-06 | 856 | 215 | 21 | M4500 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP2 CYP4B1 PRDM1 PTPRC NID1 MME CDC73 PPIP5K2 MED23 HSPA1A HSPA1B FNDC3B ARID4A RBBP6 PUM2 SEMA5A HEATR5A CRK PHF20L1 LMO7 SETD7 | 1.48e-05 | 888 | 215 | 21 | MM1018 |
| Coexpression | HASLINGER_B_CLL_WITH_11Q23_DELETION | 3.45e-05 | 23 | 215 | 4 | M11509 | |
| Coexpression | GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP | 4.16e-05 | 199 | 215 | 9 | M8080 | |
| Coexpression | GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP | HSP90B1 LRRC37A2 SLIT2 MLLT3 RAB27B FLT4 ZNF652 SIRT4 ZC2HC1A | 4.16e-05 | 199 | 215 | 9 | M5759 |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP | 4.33e-05 | 200 | 215 | 9 | M7077 | |
| Coexpression | GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN | 4.33e-05 | 200 | 215 | 9 | M8552 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 4.33e-05 | 200 | 215 | 9 | M5276 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP | 4.33e-05 | 200 | 215 | 9 | M4024 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | CCDC71L GALNT1 SPTAN1 CFB PTPRC C3 ATP11A UQCRC2 HSPA1A RAB27B PLXNB1 WDR72 SLC25A24 FNDC3B ABI1 NEDD4L ERO1A ZNF503 ERGIC1 RNPEP LMO7 SLC6A20 PAH SETD7 IL1R1 | 5.21e-05 | 1276 | 215 | 25 | M39173 |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | 5.97e-05 | 259 | 215 | 10 | M40029 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | HIVEP2 PDE9A ACHE MECOM SLIT2 MME RAB27B FAT4 NEDD4L PHF20L1 LMO7 DNAJC15 IL1R1 DCLK1 | 7.85e-05 | 504 | 215 | 14 | M2157 |
| Coexpression | LIU_VAV3_PROSTATE_CARCINOGENESIS_UP | 9.37e-05 | 89 | 215 | 6 | M215 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP | MAP1B SYT9 EHD1 DNAJB5 TRIM36 HSPA1A HSPA1B FNDC3B DMXL2 NEDD4L RELB IL1R1 GABRA1 | 1.00e-04 | 452 | 215 | 13 | M18685 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN | 1.06e-04 | 91 | 215 | 6 | M2154 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | GALNT1 PDE9A CFB GK C3 MED23 PLEKHA7 RAB27A WDR72 AMPD3 DMXL2 ZNF652 POR ZNF503 EFNA5 PHF20L1 IL1R1 | 1.12e-04 | 726 | 215 | 17 | M4210 |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | IMPDH1 UNC5B MECOM HPSE SLIT2 FNDC1 ADAMTS15 MLLT3 ASTN2 PLEC TRIM36 HSPA1A HSPA1B PLXNA2 NOVA2 NPR1 SYT6 GRID1 ZNF503 SLC6A20 MKX DCLK1 | 1.36e-04 | 1115 | 215 | 22 | M10371 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | NLGN3 FAT2 NLGN4X RAB27A PLXNB1 FNDC3B FLNC TNC NLGN4Y OBSL1 HEATR5A NLGN1 MKX LTA4H DCLK1 | 1.40e-04 | 600 | 215 | 15 | M39055 |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.42e-04 | 137 | 215 | 7 | M40313 | |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN | 1.48e-04 | 235 | 215 | 9 | M2256 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | CCDC71L MAP1B UNC5B FNDC1 NLGN4X NID1 RAB27A DIP2B MKX IL1R1 | 1.69e-04 | 294 | 215 | 10 | M1804 |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | GALNT1 MAP1B PRKD3 NID1 FKBP1A PLXNA2 FNDC3B FLNB RBBP6 IL1R1 | 1.74e-04 | 295 | 215 | 10 | M39121 |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | CCDC71L ACHE SSBP3 PRDM1 C3 MME C9 ZSWIM4 PLXNA2 FLNB FLNC TNC SEMA5A EFNA5 DNAJC15 NT5C2 SETD7 FUT8 CTSK | 1.52e-05 | 615 | 213 | 19 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CCDC71L HIVEP2 IRAK1 HPSE GK EHD1 FNDC3B AMPD3 DMXL2 PELI1 RELB | 2.62e-09 | 191 | 216 | 11 | 0b296404ebad0aadb75737f8c0462ec6934fc8bb |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | ACHE CYP4B1 ARID4A KDM5A SEMA5A FREM3 SLC6A4 TGM1 TMEM132D DCLK1 | 1.60e-08 | 176 | 216 | 10 | 458720776b0151cd55acc352d509599cb62f0ca8 |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 1.98e-08 | 180 | 216 | 10 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-08 | 185 | 216 | 10 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 3.15e-08 | 189 | 216 | 10 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.47e-08 | 191 | 216 | 10 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.65e-08 | 197 | 216 | 10 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.88e-08 | 198 | 216 | 10 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 1.26e-07 | 166 | 216 | 9 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-07 | 167 | 216 | 9 | 78909f685ccd1321064eb0887caf9263e0e54879 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | C7orf57 MDH1B MAPK8IP1 DNAH3 DNAH2 ARHGAP39 C11orf16 PITPNM1 DNAH12 | 2.29e-07 | 178 | 216 | 9 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.64e-07 | 181 | 216 | 9 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 2.89e-07 | 183 | 216 | 9 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-07 | 184 | 216 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-07 | 184 | 216 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 3.03e-07 | 184 | 216 | 9 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-07 | 184 | 216 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 3.03e-07 | 184 | 216 | 9 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-07 | 185 | 216 | 9 | e583f6601f9ed79b0b23d2f9426a4ba8b969230b | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 3.17e-07 | 185 | 216 | 9 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-07 | 186 | 216 | 9 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.32e-07 | 186 | 216 | 9 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-07 | 186 | 216 | 9 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 3.47e-07 | 187 | 216 | 9 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HSP90B1 DNAJB9 PRDM1 CORO2B CHAC1 FNDC3B CACNA1S ERGIC1 FUT8 | 3.63e-07 | 188 | 216 | 9 | 70184b14160b71a1fecd7f195e5a16c5937738a2 |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.80e-07 | 189 | 216 | 9 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 3.80e-07 | 189 | 216 | 9 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.15e-07 | 191 | 216 | 9 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.15e-07 | 191 | 216 | 9 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.34e-07 | 192 | 216 | 9 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HSP90B1 DNAJB9 PRDM1 CORO2B CHAC1 FNDC3B CACNA1S ERGIC1 FUT8 | 4.94e-07 | 195 | 216 | 9 | f9a90cd7b4e99a0947fdb3645f7787d02b0f7ca0 |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.16e-07 | 196 | 216 | 9 | 64c2abc0087bf2ae547932377f3662e3be1cc63e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.16e-07 | 196 | 216 | 9 | c2bbb48c4aa979b03cb6f4ce9f351f492977c992 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.38e-07 | 197 | 216 | 9 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.38e-07 | 197 | 216 | 9 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.38e-07 | 197 | 216 | 9 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.61e-07 | 198 | 216 | 9 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.85e-07 | 199 | 216 | 9 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.85e-07 | 199 | 216 | 9 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.10e-07 | 200 | 216 | 9 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | supra_basal_cell|World / shred by cell class for nasal brushing | 6.10e-07 | 200 | 216 | 9 | 542bdcec563644e01887fd85eb158b32db439b03 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 6.10e-07 | 200 | 216 | 9 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.10e-07 | 200 | 216 | 9 | d64895354218ebd0217011bae0967a6883bbd1cd | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-07 | 200 | 216 | 9 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 165 | 216 | 8 | 082f62f759a0b16ab56fad6dd4c4dd70b4f18a5c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-06 | 170 | 216 | 8 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.86e-06 | 170 | 216 | 8 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-06 | 170 | 216 | 8 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-06 | 170 | 216 | 8 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-06 | 171 | 216 | 8 | 05fcc72df50a380a913821b5781d9621df37d328 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-06 | 171 | 216 | 8 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-06 | 171 | 216 | 8 | 48fc4eca18b102b5ec5050f758281292ee8e10c6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-06 | 171 | 216 | 8 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 2.22e-06 | 174 | 216 | 8 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-06 | 175 | 216 | 8 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-06 | 175 | 216 | 8 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-06 | 175 | 216 | 8 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.41e-06 | 176 | 216 | 8 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 2.74e-06 | 179 | 216 | 8 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-06 | 179 | 216 | 8 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-06 | 179 | 216 | 8 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 180 | 216 | 8 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-06 | 180 | 216 | 8 | f103e161e966c257eac97e1b30a461c4ed9cafc2 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-06 | 182 | 216 | 8 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-06 | 182 | 216 | 8 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 3.23e-06 | 183 | 216 | 8 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.23e-06 | 183 | 216 | 8 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-06 | 184 | 216 | 8 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-06 | 184 | 216 | 8 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 184 | 216 | 8 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.36e-06 | 184 | 216 | 8 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-06 | 184 | 216 | 8 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.42e-06 | 130 | 216 | 7 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.50e-06 | 185 | 216 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.50e-06 | 185 | 216 | 8 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.64e-06 | 186 | 216 | 8 | 375642f353842184792a834361284d6897c728de | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 186 | 216 | 8 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 186 | 216 | 8 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-06 | 187 | 216 | 8 | 71eb26ebf60cb0848e5bf1cd01edccda621aecd8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-06 | 187 | 216 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 3.78e-06 | 187 | 216 | 8 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.94e-06 | 188 | 216 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-06 | 189 | 216 | 8 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-06 | 189 | 216 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.09e-06 | 189 | 216 | 8 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 189 | 216 | 8 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-06 | 190 | 216 | 8 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-06 | 190 | 216 | 8 | 992539c380576bf810c00a5f926cf1ee7d57dcf5 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.26e-06 | 190 | 216 | 8 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-06 | 190 | 216 | 8 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.26e-06 | 190 | 216 | 8 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.26e-06 | 190 | 216 | 8 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-06 | 191 | 216 | 8 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-06 | 192 | 216 | 8 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-06 | 192 | 216 | 8 | 6417468829517a0f6e04e7e44eec1622001d4c5c | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-06 | 192 | 216 | 8 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-06 | 193 | 216 | 8 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.78e-06 | 193 | 216 | 8 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.78e-06 | 193 | 216 | 8 | 5703a6faaee82cbad5ce73429bdf1b0f47b37ee0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.78e-06 | 193 | 216 | 8 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| Drug | Flavonoids | MYH6 HIVEP2 CYP4B1 MATR3 CDKL3 IRAK1 DNAJB9 HPSE NLGN3 GK MLLT3 MTARC2 MME RAB27B IMPG2 AMPD3 ABI1 A1CF DRP2 SYT6 APOB NLGN1 CRK TGM1 SLC10A1 RNPEP IL1R1 SLC14A2 DCLK1 | 1.01e-06 | 1136 | 214 | 29 | ctd:D005419 |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; HL60; HT_HG-U133A | ACHE NID1 ASTN2 DNAJB5 RAB27B NPR1 FLT4 ISYNA1 SEMA5A APOB IL1R1 | 2.65e-06 | 196 | 214 | 11 | 2742_UP |
| Drug | AGEPC | MAP1B HPSE PRKD3 KAT8 MME PLCG1 APOB PRPF8 CRK SLC6A20 LTA4H LTF IL1R1 GABRA1 | 7.59e-06 | 356 | 214 | 14 | CID000461545 |
| Drug | Mercuric Chloride | HSP90B1 IMPDH2 ACHE DNAJB9 ALKBH5 CFB EHD1 GNL2 C3 FGG C9 HSPA1A HSPA1B FKBP1A CHAC1 DMXL2 ABI1 IARS1 POR APOB DPP3 SLC6A4 RNPEP NT5C2 CTSK DCLK1 AFG1L | 1.23e-05 | 1155 | 214 | 27 | ctd:D008627 |
| Drug | Leupeptin hydrochloride | HSP90B1 SPTA1 SPTAN1 CLPX BPHL C3 MME APOB CTSA TGM1 RNPEP CTSK | 1.28e-05 | 276 | 214 | 12 | CID000003910 |
| Drug | NSC-601074 | 1.64e-05 | 17 | 214 | 4 | CID000353295 | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | MAP1B CYP4B1 SPTAN1 NEK9 ASTN2 ATP11A PLXNB1 AMPD3 ZNF652 PLEKHA6 | 1.67e-05 | 195 | 214 | 10 | 3525_DN |
| Drug | Clofazimine [2030-63-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.74e-05 | 196 | 214 | 10 | 5642_UP | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | KLHL29 MINAR1 KIF5A DMXL2 NEDD4L OBSL1 NLGN1 C11orf16 LMO7 SLC6A20 | 1.90e-05 | 198 | 214 | 10 | 3638_UP |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | SPTAN1 KAT8 DNAJB5 PLXNB1 CHAC1 DCAF15 FLT4 PLEKHA6 PITPNM1 CTSK | 1.99e-05 | 199 | 214 | 10 | 2322_DN |
| Drug | cyclopentenyl cytosine | 2.63e-05 | 19 | 214 | 4 | CID000072828 | |
| Drug | cupric chloride | HSP90B1 ACHE SPTAN1 EML6 KIF5A FGG HSPA1A HSPA1B DDX4 CHAC1 POR SEMA5A APOB PRPF8 ZNF503 RNPEP LTA4H ENDOG | 2.65e-05 | 623 | 214 | 18 | ctd:C029892 |
| Drug | NSC265489 | 2.75e-05 | 127 | 214 | 8 | CID000003238 | |
| Drug | Toluene | HIVEP2 CYP4B1 MECOM DNAJB9 SSTR4 FNDC1 NID1 C3 UQCRC2 FAT4 ARID4A POR PELI1 SEMA5A RELB PHF20L1 LMO7 SLC6A20 SLC14A2 GABRA1 | 2.88e-05 | 749 | 214 | 20 | ctd:D014050 |
| Disease | Joubert syndrome 1 | 3.38e-07 | 21 | 212 | 5 | C4551568 | |
| Disease | Schizophrenia | AHI1 ACHE KAT8 ASTN2 NLGN2 HSPA1A HSPA1B PLXNA2 GRID1 NLGN1 PLEKHA6 PITPNM1 ADAMTS12 SLC6A4 PDIK1L PAH FUT8 CTSK DCLK1 GABRA1 | 6.63e-06 | 883 | 212 | 20 | C0036341 |
| Disease | Colorectal Carcinoma | MAP1B SYT9 HTR3C CORO2B NLGN4X SACS ADAMTS15 NID1 UQCRC2 FLNC DNAH3 POLD1 TSPEAR GRID1 APOB LMO7 DCLK1 | 1.44e-05 | 702 | 212 | 17 | C0009402 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.50e-05 | 152 | 212 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Autistic Disorder | AHI1 HTR3C NLGN3 NLGN4X KAT8 ASTN2 SEMA5A NLGN1 SLC6A4 GABRA1 | 2.11e-05 | 261 | 212 | 10 | C0004352 |
| Disease | Intellectual Disability | AHI1 HIVEP2 MAP1B SACS KAT8 KIF5A MED23 TCTN1 CNDP1 KDM5A ARMC9 NT5C2 FUT8 | 2.35e-05 | 447 | 212 | 13 | C3714756 |
| Disease | heart rate | 3.91e-05 | 225 | 212 | 9 | EFO_0004326 | |
| Disease | erythema nodosum (is_marker_for) | 5.14e-05 | 2 | 212 | 2 | DOID:0080750 (is_marker_for) | |
| Disease | boutonneuse fever (is_marker_for) | 5.14e-05 | 2 | 212 | 2 | DOID:14095 (is_marker_for) | |
| Disease | spondylocarpotarsal synostosis syndrome (implicated_via_orthology) | 5.14e-05 | 2 | 212 | 2 | DOID:0090116 (implicated_via_orthology) | |
| Disease | anterior uveitis (is_marker_for) | 5.14e-05 | 2 | 212 | 2 | DOID:1407 (is_marker_for) | |
| Disease | conjunctivitis (is_marker_for) | 5.14e-05 | 2 | 212 | 2 | DOID:6195 (is_marker_for) | |
| Disease | coronary artery disease | CCDC71L TDRD15 HIVEP2 MAP1B MECOM NEK9 CFB FNDC1 ASTN2 PLCG1 PLEKHA7 WDR72 FNDC3B FAT4 ARID4A ZNF652 SEMA5A APOB FIGN TMEM132D NT5C2 SLC14A2 | 5.41e-05 | 1194 | 212 | 22 | EFO_0001645 |
| Disease | Familial aplasia of the vermis | 6.13e-05 | 30 | 212 | 4 | C0431399 | |
| Disease | Antihypertensive use measurement | 1.37e-04 | 265 | 212 | 9 | EFO_0009927 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.53e-04 | 3 | 212 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | complement C3D fragment measurement | 1.53e-04 | 3 | 212 | 2 | EFO_0020277 | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.53e-04 | 3 | 212 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | membranous glomerulonephritis (is_implicated_in) | 1.53e-04 | 3 | 212 | 2 | DOID:10976 (is_implicated_in) | |
| Disease | glycerol kinase deficiency (implicated_via_orthology) | 1.53e-04 | 3 | 212 | 2 | DOID:0060363 (implicated_via_orthology) | |
| Disease | sickle cell anemia (is_implicated_in) | 1.91e-04 | 16 | 212 | 3 | DOID:10923 (is_implicated_in) | |
| Disease | smoking behavior, body mass index | 2.71e-04 | 123 | 212 | 6 | EFO_0004318, EFO_0004340 | |
| Disease | Age-related macular degeneration | 2.76e-04 | 18 | 212 | 3 | cv:C0242383 | |
| Disease | glucuronate measurement | 2.76e-04 | 18 | 212 | 3 | EFO_0010486 | |
| Disease | lepromatous leprosy (is_marker_for) | 3.05e-04 | 4 | 212 | 2 | DOID:10887 (is_marker_for) | |
| Disease | factor VIII deficiency (is_marker_for) | 3.05e-04 | 4 | 212 | 2 | DOID:12134 (is_marker_for) | |
| Disease | alpha-parvin measurement | 3.05e-04 | 4 | 212 | 2 | EFO_0802271 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 3.25e-04 | 19 | 212 | 3 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | pulse pressure measurement | CCDC71L TDRD15 MYH6 MAP1B NEK9 CFB PRKD3 KLHL29 FNDC1 PLEKHM2 ADAMTS15 PLEKHA7 DIP2B FNDC3B FLNB AMPD3 KDM5A HEATR5A FIGN CRK NT5C2 SLC14A2 | 4.67e-04 | 1392 | 212 | 22 | EFO_0005763 |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 5.07e-04 | 5 | 212 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 5.07e-04 | 5 | 212 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | nidogen-1 measurement | 5.07e-04 | 5 | 212 | 2 | EFO_0008249 | |
| Disease | JOUBERT SYNDROME 17 | 5.07e-04 | 5 | 212 | 2 | C3553264 | |
| Disease | renal system measurement, blood urea nitrogen measurement | 5.09e-04 | 22 | 212 | 3 | EFO_0004741, EFO_0004742 | |
| Disease | Liver Cirrhosis, Experimental | PRTG ACHE SPTAN1 HPSE GK PTPRC NID1 MME FKBP1A CNDP1 SLC25A24 ISYNA1 XPNPEP2 SLC10A1 LTA4H | 5.14e-04 | 774 | 212 | 15 | C0023893 |
| Disease | non-high density lipoprotein cholesterol measurement | TDRD15 GALK2 SPTA1 SSBP3 CFB PRDM1 WDR72 DIP2B A1CF POR APOB HEATR5A DPP3 GSTM5 | 6.94e-04 | 713 | 212 | 14 | EFO_0005689 |
| Disease | Bipolar Disorder | HSP90B1 PDE9A MLLT3 ASTN2 PLCG1 GRID1 NLGN1 SLC6A4 DCLK1 GABRA1 AFG1L | 7.19e-04 | 477 | 212 | 11 | C0005586 |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 7.56e-04 | 6 | 212 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | neuroimaging measurement | PRTG MAP1B SSBP3 CFB SLIT2 STAC2 PLEC ZSWIM4 PLEKHA7 PLXNA2 IP6K2 DIP2B AMPD3 ARMC9 SLC6A4 SLC6A20 MKX DCLK1 | 7.58e-04 | 1069 | 212 | 18 | EFO_0004346 |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 8.42e-04 | 26 | 212 | 3 | OBA_2045194 | |
| Disease | smoking behavior | 8.56e-04 | 341 | 212 | 9 | EFO_0004318 | |
| Disease | Retinitis Pigmentosa | 9.44e-04 | 104 | 212 | 5 | C0035334 | |
| Disease | familial hyperlipidemia | 1.03e-03 | 106 | 212 | 5 | MONDO_0001336 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 1.05e-03 | 28 | 212 | 3 | DOID:8466 (biomarker_via_orthology) | |
| Disease | ER membrane protein complex subunit 4 measurement | 1.05e-03 | 7 | 212 | 2 | EFO_0801580 | |
| Disease | Periventricular Nodular Heterotopia | 1.05e-03 | 7 | 212 | 2 | C1868720 | |
| Disease | fibrinogen measurement | 1.16e-03 | 109 | 212 | 5 | EFO_0004623 | |
| Disease | Age related macular degeneration | 1.29e-03 | 30 | 212 | 3 | C0242383 | |
| Disease | reading and spelling ability | 1.31e-03 | 166 | 212 | 6 | EFO_0005301 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 1.40e-03 | 8 | 212 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | X-17676 measurement | 1.40e-03 | 8 | 212 | 2 | EFO_0800785 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.40e-03 | 8 | 212 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 1.40e-03 | 8 | 212 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | bilirubin measurement | 1.44e-03 | 442 | 212 | 10 | EFO_0004570 | |
| Disease | creatinine measurement, glomerular filtration rate | 1.60e-03 | 117 | 212 | 5 | EFO_0004518, EFO_0005208 | |
| Disease | Complement deficiency disease | 1.70e-03 | 33 | 212 | 3 | C0272242 | |
| Disease | internet addiction disorder | 1.70e-03 | 33 | 212 | 3 | EFO_0803368 | |
| Disease | cortical surface area measurement | PRTG MECOM SSBP3 KLHL29 SLIT2 MLLT3 ASTN2 MED23 ZSWIM4 PLEKHA7 PLXNA2 IP6K2 FLNB ABI1 SEMA5A ARHGAP39 EFNA5 NT5C2 CTSK DCLK1 | 1.76e-03 | 1345 | 212 | 20 | EFO_0010736 |
| Disease | Atypical hemolytic-uremic syndrome | 1.79e-03 | 9 | 212 | 2 | cv:C2931788 | |
| Disease | Major depression, single episode | 1.79e-03 | 9 | 212 | 2 | C0024517 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 1.79e-03 | 9 | 212 | 2 | EFO_0010613 | |
| Disease | C3 glomerulopathy | 1.79e-03 | 9 | 212 | 2 | C4087273 | |
| Disease | Hemolytic-uremic syndrome | 1.79e-03 | 9 | 212 | 2 | cv:C0019061 | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 1.82e-03 | 72 | 212 | 4 | DOID:9744 (is_marker_for) | |
| Disease | Amphetamine-Related Disorders | 2.11e-03 | 75 | 212 | 4 | C0236733 | |
| Disease | Amphetamine Abuse | 2.11e-03 | 75 | 212 | 4 | C0236807 | |
| Disease | Amphetamine Addiction | 2.11e-03 | 75 | 212 | 4 | C0236804 | |
| Disease | angina pectoris | 2.13e-03 | 125 | 212 | 5 | EFO_0003913 | |
| Disease | hippocampal CA3 volume | 2.19e-03 | 36 | 212 | 3 | EFO_0009395 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 2.23e-03 | 10 | 212 | 2 | C2931788 | |
| Disease | cardiovascular system disease (is_marker_for) | 2.23e-03 | 10 | 212 | 2 | DOID:1287 (is_marker_for) | |
| Disease | response to carboplatin, response to antineoplastic agent | 2.23e-03 | 10 | 212 | 2 | GO_0097327, GO_0097328 | |
| Disease | myelodysplastic syndrome | 2.23e-03 | 10 | 212 | 2 | EFO_0000198 | |
| Disease | response to vaccine, cytokine measurement | 2.61e-03 | 131 | 212 | 5 | EFO_0004645, EFO_0004873 | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.70e-03 | 132 | 212 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 2.71e-03 | 11 | 212 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | Hemolytic-Uremic Syndrome | 2.71e-03 | 11 | 212 | 2 | C0019061 | |
| Disease | beta thalassemia (is_marker_for) | 2.71e-03 | 11 | 212 | 2 | DOID:12241 (is_marker_for) | |
| Disease | Nonsyndromic Deafness | 2.80e-03 | 81 | 212 | 4 | C3711374 | |
| Disease | cortical thickness | PRTG GALK2 MECOM SSBP3 KLHL29 SLIT2 ASTN2 PLEC ZSWIM4 TRIM36 PLEKHA7 PLXNA2 IP6K2 DIP2B FLNB CRK EFNA5 | 2.94e-03 | 1113 | 212 | 17 | EFO_0004840 |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 3.23e-03 | 12 | 212 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | pulmonary function measurement, forced expiratory volume, smoking behaviour measurement | 3.23e-03 | 12 | 212 | 2 | EFO_0003892, EFO_0004314, EFO_0005671 | |
| Disease | myeloid white cell count | CCDC71L AHI1 EML6 MECOM C7orf57 KLHL29 PTPRC SUPT5H C3 PLXNB1 SLC25A24 FLNB AMPD3 CRK SLC6A4 | 3.33e-03 | 937 | 212 | 15 | EFO_0007988 |
| Disease | total hip arthroplasty, osteoarthritis | 3.42e-03 | 42 | 212 | 3 | EFO_0009806, MONDO_0005178 | |
| Disease | autistic disorder (is_implicated_in) | 3.42e-03 | 42 | 212 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | mean arterial pressure | PABPC4 EML6 MECOM PRKD3 TRIM36 PLEKHA7 NPR1 ZNF652 FIGN NT5C2 | 3.44e-03 | 499 | 212 | 10 | EFO_0006340 |
| Disease | intermediate density lipoprotein measurement | 3.62e-03 | 87 | 212 | 4 | EFO_0008595 | |
| Disease | childhood gender nonconformity | 3.65e-03 | 43 | 212 | 3 | EFO_0020103 | |
| Disease | illegal drug consumption | 3.80e-03 | 13 | 212 | 2 | EFO_0005431 | |
| Disease | methylcobalamin deficiency type cblE, response to antineoplastic agent | 3.80e-03 | 13 | 212 | 2 | GO_0097327, MONDO_0009354 | |
| Disease | amino acid measurement | NACA2 KLHL29 SLIT2 ASTN2 PLXNA2 FAT4 SEMA5A NLGN1 SLC6A4 DNAH12 SETD7 DCLK1 | 3.85e-03 | 678 | 212 | 12 | EFO_0005134 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.92e-03 | 144 | 212 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | lobe attachment | 3.94e-03 | 207 | 212 | 6 | EFO_0007667 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 4.16e-03 | 45 | 212 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 4.16e-03 | 45 | 212 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 4.25e-03 | 91 | 212 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | hemorrhoid | 4.28e-03 | 147 | 212 | 5 | EFO_0009552 | |
| Disease | photoreceptor cell layer thickness measurement | 4.40e-03 | 148 | 212 | 5 | EFO_0803370 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 4.42e-03 | 14 | 212 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | wet macular degeneration | 4.42e-03 | 14 | 212 | 2 | EFO_0004683 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RAPEIIIGKSYDYGI | 856 | Q13523 | |
| VVKDEGSYFLVYGAP | 361 | P22303 | |
| PDSVDYRKKGYVTPV | 116 | P43235 | |
| AYDVLSDPKKRGLYD | 51 | O75953 | |
| EPAYLTVGTDVSAKY | 6 | P29374 | |
| AVKYKYSALIEVPDG | 186 | Q9H4A4 | |
| SYVPIFEKDRYSGEN | 16 | Q9NQI0 | |
| GKEGQPREYYTLDSI | 46 | Q6P1J9 | |
| GYIRAPTKESSEEEY | 601 | O76031 | |
| AKPVDKDSYVRYTRG | 301 | Q9NQ94 | |
| TAEPYDGTKARLYSL | 111 | Q9NW68 | |
| TLAVYKSPEYESLGF | 56 | P49902 | |
| KDDSGRPVSSYYEKE | 381 | Q8N157 | |
| GTYFKPSLYESDKDR | 1261 | Q96Q42 | |
| YPVSGAKRKYQEDSD | 51 | Q6P6C2 | |
| YKVEESGYAGFILPI | 71 | P42568 | |
| YRAPELVLKDTSYGK | 166 | Q8IVW4 | |
| GKLDYEATPAYSLVI | 1271 | Q6V0I7 | |
| RELPAAGKLYYLTSE | 286 | Q8WV93 | |
| ACEPGVDYVYKTRLV | 1536 | P01024 | |
| NGKVATAPTRYYDDI | 91 | Q56P03 | |
| YIRKPIDYTVLDDVG | 136 | Q8IZP0 | |
| TAYISSEGRIKYDKP | 141 | Q8WXA8 | |
| LYAKIAEAFGIAPTE | 61 | Q8TF64 | |
| KALALDPYEEYFTTG | 2946 | Q8TDJ6 | |
| QRAKLTISPDYAYGA | 71 | P62942 | |
| EYALTTRAGPSYAKL | 151 | P16066 | |
| SYYDILGVPKSASER | 26 | Q9UBS3 | |
| PDGLYKFTLYAVDTR | 1161 | O75129 | |
| LAIRSEDPEKYYLNG | 741 | P58397 | |
| GYFYVLAPKVVDGTL | 626 | Q8TE58 | |
| SKYNPVGASELRDLY | 391 | Q01432 | |
| YVEKYRPASASVSAL | 186 | P46108 | |
| DYFVVAGLTDVSKPL | 11 | Q7Z401 | |
| LAEKYGIPYFETSAA | 151 | P51159 | |
| LADKYGIPYFETSAA | 151 | O00194 | |
| YCPDYRIGKVTSEEL | 191 | P22695 | |
| RFLSLEYSPAGKEYV | 381 | Q9C0H5 | |
| TYLPRDHDSYGVDKK | 396 | Q01201 | |
| RYISAAPGAEAKYRS | 661 | Q8TB72 | |
| VVIKYVPYVGDSKRA | 381 | Q9NPH2 | |
| VPYVGDSKRALDEYT | 386 | Q9NPH2 | |
| DVAYSSVPYEKGFAL | 376 | P09960 | |
| TSPVRYKEEEYKSGL | 1121 | Q03112 | |
| QYAPGYDKVKDISEV | 661 | P00751 | |
| YPSGKVYVAAVRLER | 901 | O75147 | |
| FTAEGYLYVQEKRPA | 266 | A1A4S6 | |
| AVAAAAPRAVAPYKY | 511 | Q13310 | |
| YKGDLLEVEYSTEPG | 146 | Q8WUE5 | |
| YAEKYSGILEGPVDR | 71 | Q5HY92 | |
| TGTYDKKVTIYDPRA | 281 | Q5XUX1 | |
| PGYTGNIAKDVDAYL | 286 | Q9H079 | |
| AVLERAKPEYISKTY | 396 | Q13823 | |
| VDETYRKPVLGKAYE | 201 | P83369 | |
| GDYSYEIIEKTTRTP | 1936 | P46821 | |
| SGYSDSAVLKLAEPY | 506 | P43243 | |
| VYPEIIERAGYSLEK | 316 | Q9UNF1 | |
| SLELKKEVPGYGYTD | 1566 | A6NM11 | |
| KEVPGYGYTDKLILA | 1571 | A6NM11 | |
| SLELKKEVPGYGYTD | 1566 | A6NMS7 | |
| KEVPGYGYTDKLILA | 1571 | A6NMS7 | |
| KIRYESGDHVAVYPA | 311 | P16435 | |
| RLGLDSEEDYYTPQK | 511 | Q8TD19 | |
| DKPVYYALEGSVAIA | 311 | Q14409 | |
| SSYVEKKYTLGDAPD | 26 | P46439 | |
| KKYTLGDAPDYDRSQ | 31 | P46439 | |
| AYAYKPIGASSVDVR | 366 | Q9UHH9 | |
| YGDADLEKPTAIAYR | 2401 | Q9UKN7 | |
| RGVFPAYYAIEVTKE | 536 | Q9UQF2 | |
| PGKEIYRKSNISVYE | 236 | Q9H7Z6 | |
| IYLLKYSVGRPDKEE | 106 | Q7Z3E5 | |
| AVYKVSEYARRFGVP | 346 | P12268 | |
| DRYFKGIVYAISPDR | 66 | O15075 | |
| KDGTYAVTYVPLTAG | 1186 | O75369 | |
| NKDGTYAVTYIPDKT | 1571 | O75369 | |
| SYKGETKAFYPEEIS | 106 | P0DMV9 | |
| VERYYADIAKLPAIS | 1811 | O75051 | |
| SGIPFLDYKVYAERI | 1561 | O43157 | |
| IDKDSGPYGTIDYTI | 2506 | Q9NYQ8 | |
| SRASEDYVAPPKYKS | 206 | Q8IYA7 | |
| SSYRPKAIYLDIDGR | 6 | O76083 | |
| GLGKVYYREDLSPSI | 116 | P14543 | |
| IVPTVYEDKSGKQRY | 191 | Q969X5 | |
| DKDRTYAVSYVPKVA | 331 | Q14315 | |
| KAYYQRSDGSLAPEK | 426 | Q01415 | |
| YFAVTEIRKLYPEGK | 181 | Q9ULK4 | |
| GTYRPEYAVNSIKTD | 696 | P08473 | |
| TEPAYIEYKTSKEGS | 511 | Q9P265 | |
| ARKYTTPIDLLGYEF | 2961 | Q6ZR08 | |
| AAYTGLKERVIKTPY | 476 | P63132 | |
| ESGSKYYKEIPLSEI | 451 | O94806 | |
| YQSERVEEKGATYPS | 826 | Q8WWI1 | |
| GEGKPYYEVRLASVL | 206 | Q9NY33 | |
| PLKFGSYAYTRAEVV | 181 | P14867 | |
| PGEQYFYLKARSVAE | 66 | Q96JA3 | |
| NLYGYPEGKDVLRET | 461 | Q8N2Q7 | |
| GTLAYLPEEYIKTGR | 386 | P51617 | |
| GEYFLKVLIPSYAAG | 31 | Q9UNW9 | |
| PSLLYGVKVRAQSYD | 726 | P29375 | |
| DNPRYKEGDLTLYAI | 441 | Q9Y251 | |
| LGAPDEYIEKLATIY | 311 | P00439 | |
| PYVAIKAYTAVEGDE | 231 | A6NI72 | |
| PYVAIKAYTAVEGDE | 206 | A8MVU1 | |
| GKYAIPTIDAEAYAI | 216 | Q7Z6E9 | |
| AVYKVAEYARRFGVP | 346 | P20839 | |
| PKRLDSADAKVYSGY | 926 | Q2VWP7 | |
| YSRGIYDGDLKDKVP | 141 | Q14973 | |
| KLFLTGESYAGIYIP | 171 | P10619 | |
| GYLLPDTKAYGDRIE | 726 | P14625 | |
| VAPDASVLVKYSGYL | 51 | O75344 | |
| YGYPEGKDTLRETIK | 441 | Q9NZ94 | |
| YQPAKYTRILADKVG | 291 | Q8NFZ3 | |
| LYGYPEGKDTLRETI | 406 | Q8NFZ3 | |
| IGFVYPAYASIKAIE | 61 | Q96HR9 | |
| FKVGPEADKYRLTYA | 291 | P02679 | |
| FYIISPGVTKVDYGD | 381 | Q10472 | |
| KDNVPKATGVLYDYV | 4071 | P04114 | |
| PALEGTYARKSDYIS | 181 | O60308 | |
| YSIYEKDVEGDSVPK | 756 | Q86XA9 | |
| TSYKYEVALAGPALE | 276 | Q9NWV8 | |
| GDGNIRYYEISTEKP | 291 | Q9UQ03 | |
| EKPAYYALEGSVAIA | 311 | Q14410 | |
| DYKEVPFDALTYLTG | 3716 | Q8TD57 | |
| YKAIDSNAEDVGPIY | 1021 | Q13698 | |
| GESLRYAEYLQPSAK | 11 | Q9Y5T4 | |
| YYHVPVKRSEKAVDA | 21 | Q8NEG2 | |
| SFPYSYEVALSDKGR | 311 | Q53EP0 | |
| PETEGKVKEYILSYA | 386 | Q4ZHG4 | |
| AVLGGYDTKEVTFYP | 116 | Q9BUX1 | |
| KRREYPDGTVKTVYA | 1296 | Q9HC77 | |
| KELSRDAYPGIYALD | 491 | Q8IX06 | |
| RDKPVYYALEGSVAI | 316 | P32189 | |
| YRAPELLLGAKEYST | 591 | Q9UQ88 | |
| SDEVPDGIKSASYKY | 106 | Q96HE7 | |
| YYSVEKIGSLRVGDP | 316 | Q969Z3 | |
| IAGRADCPYYAKTEL | 6 | Q5I0G3 | |
| YTIFYSISGPGVDKE | 166 | Q08554 | |
| QDPGSKAVADRYAVY | 21 | P52803 | |
| ISALAEGTKSYVPYR | 266 | Q12840 | |
| AVYEYFRAKGTNPLE | 686 | Q9ULK0 | |
| KDVYGYSSCRALVPD | 96 | Q8N9Z2 | |
| EPDYAKAVYSRGDPK | 96 | P13584 | |
| KAVYSRGDPKAPDVY | 101 | P13584 | |
| PVDVYAVAQRYKKIG | 431 | Q6ZMW3 | |
| SYKGETKAFYPEEIS | 106 | P0DMV8 | |
| SERTRKPLEALYGYD | 186 | Q86WA6 | |
| LETYFIPKDGSLASY | 4081 | Q9P225 | |
| VGKDKPTYDEIFYTL | 441 | Q9H4M9 | |
| LEAYGVDSLKTRYPD | 4526 | Q9NZJ4 | |
| DVYAKDGRVSYPKLH | 376 | O00411 | |
| KGYYDVPIATLDFSS | 591 | P28340 | |
| PIKASDGKTYDAYIL | 376 | P14778 | |
| DAYILYPKTVGEGST | 386 | P14778 | |
| NLYGYPEGKDVLRET | 416 | Q8NFZ4 | |
| YQPAKYTRILADKVG | 291 | Q8N0W4 | |
| LYGYPEGKDTLRETI | 406 | Q8N0W4 | |
| KLYYVLESGEGTEPE | 391 | Q66K64 | |
| EVKSRGPYIYSVLES | 151 | Q13474 | |
| DDIKALPTTYEKGEY | 321 | P02748 | |
| SKAPVKYGELIVLGY | 11 | Q96FA3 | |
| RYYPAKIEAINKEGT | 101 | A8MW92 | |
| GATEKPYLVEEAVSY | 641 | Q8IWE5 | |
| GAAPIIDVVRSGYYK | 96 | P46776 | |
| EDIYTPGYDSLLKRK | 866 | Q9UPX6 | |
| KYFTPADLAAGRVVY | 491 | P0C091 | |
| GLYPSYKVREKIETV | 551 | Q9BYC5 | |
| YSDPYVKVSLLCDGR | 396 | Q5T7P8 | |
| DFSGTSDPYVKIYLL | 251 | Q86SS6 | |
| EPYSYLVKVGVASSD | 581 | Q9NQ86 | |
| LSAGLPETSKYEYRV | 331 | O94972 | |
| PSDGQAREKLALYVY | 11 | Q9BWW4 | |
| YKLRPVAAEVYGTER | 91 | P02788 | |
| KERTDYTGKYAPAVI | 346 | Q14C87 | |
| KYVEDGLSYRALAIP | 1021 | B5MCY1 | |
| FLPRTEADGKSYVKY | 201 | Q14249 | |
| LKGEIAFDPRSAYYL | 101 | Q8N165 | |
| YYKDSREEAVLGSIP | 196 | Q6IQ23 | |
| EEPLDYYATALKSKG | 341 | P31391 | |
| GEKIAYVYPDERTAL | 141 | Q8WTS6 | |
| IPDYRSEKVGLYART | 71 | Q9Y6E7 | |
| KASLAYGIERPTYIT | 311 | O75626 | |
| SDYEILERFPGAYLK | 271 | P41252 | |
| PYKGYIGVVKDATES | 716 | O00267 | |
| RSPKENDSGVDVYYA | 296 | Q9BZV3 | |
| LPVYNAEVVAAYRGK | 131 | P13533 | |
| LVTKDYPAYALAVIG | 546 | Q9NP91 | |
| YLATDYGTIKKVRVP | 421 | Q13591 | |
| TDPYVLTEVDGKLYG | 146 | Q96KN2 | |
| GFYYRAQIKATPELE | 96 | Q9NQ32 | |
| PDLYKFVGRINVYSD | 221 | P98196 | |
| GLSGYAVRYLKPDVT | 211 | Q6URK8 | |
| KDGPYITAEEAVAVY | 796 | Q6P2Q9 | |
| YVGGESPLKEKYIDA | 156 | Q96JJ7 | |
| KFSIEIETYYLPDGG | 106 | O00562 | |
| YYKDEKEESILGSIP | 91 | Q9Y2H5 | |
| AYDELVPASLTTKYG | 221 | Q6ZU65 | |
| LKILAPSERDEGSYY | 96 | A0JD36 | |
| ILSIAYSPDGKYLAS | 151 | Q9GZS3 | |
| LSSEGKPYVTKEELY | 2416 | Q13813 | |
| GDSGKVDPVYETLRY | 196 | Q6ZMT1 | |
| DIYKDPDYVRKGSAR | 1061 | P35916 | |
| QTGPEKVKYEAYRTL | 191 | A2RTY3 | |
| TTKLDIPTAAKYEYG | 196 | Q2MV58 | |
| GKAAIDSYRIKYAPI | 916 | P24821 | |
| SIYPADGRVLKETIY | 291 | Q3MJ13 | |
| LEKIGTAEPDYGALY | 761 | P19174 | |
| KEQYFIPGTEDYRSK | 481 | O94813 | |
| VDPGRKGYVSLEDYT | 2326 | P02549 | |
| LVAPDSDVYRFYIKG | 396 | Q86WI1 | |
| LLSAERAVTGYKDPY | 4141 | Q15149 | |
| IYRGPVYALQDSTDK | 451 | Q8IZJ1 | |
| YYSVAAALTDKGEVP | 66 | A0A0A0MS04 | |
| RKTYTESYIARPDGD | 261 | Q96GY0 | |
| AAAAAALKSGYPLVY | 456 | Q96F45 | |
| YLGEKPYRSSVEEAL | 131 | Q8TF45 | |
| TYLYKHPEGSDAERK | 541 | P22735 | |
| YYSAAADITDKGEVP | 66 | A0A0K0K1G8 | |
| TAGAYLIYSSAKEPL | 646 | Q8WU66 | |
| VALVVEAKTKYPGSY | 571 | O43895 | |
| GRYDISKIPDIYDCI | 716 | O43314 | |
| YKRESGSPYSVLVDT | 51 | Q9Y2D9 | |
| KKLSPGDRVGYDYDV | 626 | P31629 | |
| AYVVKLLEEYATGPA | 486 | P31645 | |
| YYLTVKSGEEEKAPS | 436 | Q15849 | |
| SYIDGFKEPRKYIAA | 711 | P08575 | |
| PYAGIDLAVYELLKS | 356 | Q6NUK1 | |
| KSGRYDISKIPDIYD | 726 | Q6PFW1 | |
| TLYPDSGPEKRKVAY | 436 | Q9H7M6 | |
| AYARATTIYDPEKGN | 786 | Q96CT2 | |
| VYKSPASDAYIVFGE | 111 | Q9H009 | |
| DIFGASDPYVKLSLY | 36 | Q96PU5 |